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ABSTRACT 
 
 
Objectives:The World Health Organization (WHO) describes diabetes mellitus (DM) as a 
metabolic disorder of multiple etiology characterized by chronic hyperglycemia with 
disturbances of carbohydrate, fat and protein metabolism resulting from defective insulin 
secretion, insulin action or both.Studies have been going on regarding the extra-skeletal diseases 
associated with vitamin D [25(OH)D]deficiency including T2DM(type2 diabetes mellitus).This  
study is aimed to evaluate  the prevalence of vitamin D deficiency and the effect of vitamin D on 
the glycemic control and lipid profile in type II diabetes mellitus patients in a rural tertiary care 
hospital. 
Methods: Glycosylated hemoglobin (HbA1c),fasting and postprandial blood sugar,25(OH)D, 
serum insulin levels and lipid profile levels were estimated among  90 T2DM patients who were 
randomized into three groups (N= 30 ) belonging to both sex in the age group of 36-60 
years.Group oneT2DM on metformin monotherapy with normal Vitamin D levels.Group 
twoT2DM on metformin with deficient serum Vitamin D levels.Those with deficient serum 
Vitamin D level on metformin and cholecalciferol were allocated under group 
three.25(OH)Dwas measured by chemiluminescence method and HbA1c was measured by high-
performance liquid chromatography.  
Results:The results were analyzed by proper statistical methods at the end oftwelfth week.  
Intergroup comparisions were   done by  one way ANOVA and Benferroni test. For intragroup 
comparisions,two way. ANOVA and Wilk’s lambda tests were used. Significant reduction in 
fasting blood sugar (p=0.032),postprandial blood sugar(p=0.024),serum triglyceride 
level(p=0.045),insulin resistance(p=0.037) andHbA1c(p=0.046) were observed. 
 
Conclusions: Combinations of metformin and cholecalciferol significantly reduced fasting 
plasma glucose, postprandial plasma glucose,HbA1c,insulin resistance and serum 
triglyceride.Further this combination also  showed  insignificant reduction in  total cholesterol, , 
low density lipoprotein,(p  0.05),with a nonsignificant increase in  high density lipoprotein as 
compared to metformin monotherapy in T2DM.A nonsignificant decrease in fasting serum 
insulin level and a significant increase in  serum 25[OH] D level in T2DM with metformin and 
cholecalciferol therapy were observed.This study suggests vitamin D supplementation may 
improve glycemic control and lipid profile in T2DM. 
Keywords:Type 2Diabetes Mellitus,Metformin, Vitamin D, HbA1c,Serum insulin.  
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INTRODUCTION 
 The World Health Organization(WHO) describes diabetes mellitus (DM) 
as a metabolic disorder of multiple etiology characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism 
resulting from defective insulin secretion, insulin action or both. Diabetes 
mellitus is classified into four categories namely type 1 - Insulin-Dependent 
Diabetes Mellitus (IDDM),Type 2 Diabetes Mellitus (T2DM) , Type 3 - others 
and Type 4 – Gestational Diabetes Mellitus(GDM). Type 2 DM ranges from 
predominantly insulin-resistant with relative insulin deficiency to a 
predominantly insulin secretary defect, with or without insulin resistance. 
 Type I Diabetes mellitus accounts for 5 to 10% and Type 2 accounts for 
remaining 90 - 95 % of diabetic population.  
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 The incidence of both Type 1 and Type 2 DM is on the rise. DM is 
estimated by WHO that, in the year 2000, 171 million people had Diabetes and 
this expected to double by 2030. The International Diabetes Federation 
estimated that there are 285 million people with diabetes worldwide in 2010 and 
projects the absolute number will surpass 400 million by 2030. India tops the 
Diabetes Mellitus population of the world (31.7 million in the year 2000 and 
estimated to rise by 79.4 million in 2030) followed by China and United States. 
This global pandemic principally involves T2DM. 
              Recent studies have observed that there exists a role of vitamin D in the 
pathogenesis of Type2 Diabetes Mellitus.1,2,3 Several studies had reported that 
Vitamin D improves glycemic control in T2DM,4 while few studies observe no 
such effect.5 Few recent studies have observed that vitamin D deficiency exists 
in GDM. The effect of Vitamin D on serum lipids in T2DM is uncertain.6 Some 
studies have reported an inverse association of Vitamin D with triglycerides and 
total cholesterol7 level while few other studies reported no such effect. 
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AIM AND OBJECTIVES 
 
 The present study was structured for evaluating the prevalence of vitamin 
D deficiency and the effect of vitamin D in the glycemic control and lipid profile 
in type II diabetic mellitus patients in a rural tertiary care hospital. 
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REVIEW OF LITERATURE  
 
Diabetes Mellitus – An Overview                     
Type 1 DM               
                     Type 1 DM is the result of interactions of genetic, environmental, 
and immunologic factors that ultimately lead to the destruction of the pancreatic 
beta cells and insulin deficiency due to autoimmune beta cell destruction. Most 
individuals have evidence of islet-directed autoimmunity. Individuals with a 
genetic susceptibility have normal beta cell mass at birth but begin to lose beta 
cells secondary to autoimmune destruction that occurs over months to years.  
                       The major susceptibility gene for type 1DM is located in the HLA 
region on chromosome 6. Polymorphism in the HLA complex account for 40–
50% of the genetic risk of developing type 1 DM. Most individuals with type 1 
DM have the HLA DR3 and/or DR4 haplotype. Environmental triggers include 
viruses (coxsackie, rubella, entero viruses), bovine milk proteins, and 
nitrosourea compounds. Beta cell mass then begins to decrease, and insulin 
secretion progressively declines, although normal glucose tolerance is 
maintained. Features of diabetes do not become evident until a majority of beta 
cells are destroyed (70–80%). At this point, residual functional beta cells exist 
but are insufficient in number to maintain glucose tolerance 
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 Type 2 Diabetes   
                     The incidence of T2DM also increases with age, which may be 
related to decrease in exercise and muscle mass. T2DM occurs in families so that 
those with a first - degree relative with diabetes have an almost 50% life - time 
risk. Insulin resistance and abnormal insulin secretion are central to the 
development of  T2DM.  
 
         Type II DM was defined by the WHO criteria as follows: 
             (a) fasting plasma glucose ≥7.0 mmol/l; or  
 (b) with an oral glucose tolerance test, two hours after an  oral 
dose of   plasma  glucose ≥11.1 mmol/l; or 
            (c)  HbA1c > 6.5% 
  
                        Type 2 diabetes (T2DM) is marked by insulin resistance (IR). In 
IR, insulin is adequately or Overproduced by pancreatic β cells, but is 
ineffectively utilized by the target cells of adipose, hepatic and skeletal muscles 
tissues. As a response to hyperglycemia, β cells further increase insulin 
production leading to hyper insulinemia, which is often indicative of a pre-
(T2DM) stage. Hyper insulinemia is associated with hypertension, obesity, 
dyslipidemia, and glucose intolerance, These conditions are collectively known 
as metabolic syndrome.26,27 
                    Free Fatty Acids (FFA) are the major players effecting insulin 
resistance, the underlying mechanism by which this happens is still unclear.  
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Inhibition of glucose transport by FFA has been found to be linked to insulin-
mediated signals. Binding of insulin to the heterotetrameric membrane receptor 
results in insulin receptor substrate-1(IRS-1) phosphorylation and IRS-1-
associated phosphatidylinositol 3 phosphate kinase (PI3kinase) activation. 
 
Insulin Signalling Pathway 
 
This affects downstream effectors such as Akt/PKB which activates the 
glucose transporter Glut4. Glut4 is then translocated to the membrane and 
imports glucoseinto the cell.Activation of RAS – MAP kinase pathway regulates 
cell growth and glycogen synthesis.  
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The major cellular mechanism for the termination of insulin action is 
receptor mediated endocytosis and recycling. Protein kinase C – mediated serine 
phosphorylation of the insulin receptor plays a major role in the pathogenesis of 
hyperglycemia induced insulin resistance. 
 
MANAGEMENT OF DIABETES MELLITUS 
• Diet/lifestyle modification  
• Regular Exercise  
• Medication  
 Oral agents including Biguanides (Metformin), Alpha Glucosidase 
Inhibitors, Dipeptidyl peptidase 4 inhibitors,Insulin Secretagogues, 
Thiazolidinediones, Bile Acid sequestrants  Parenteral agents including 
Insulin, GLP-1 receptor agonists, Amylin agonists 
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• Management of associated conditions including Dyslipidemia, 
Hypertension, Obesity & Coronary heart disease 
• Screening and managing complications of diabetes including 
Retinopathy,  Cardiovascular  disease, Nephropathy, Neuropathy & 
others 
Metformin in Type 2 Diabetes Mellitus: 
Metformin (1,1-dimethyl biguanide), is a first line oral anti- diabetic drug. 
Metformin primarily reduces hepatic glucose production and also improves 
peripheral glucose utilization. Metformin activates AMP-dependent protein 
kinase (AMPK), a serine – threonine protein kinase which acts like a fuel gauge 
in monitoring energy status. It enters hepatic cells through organic cation 
transporters (OCT-1) and binds to the mitochondrial matrix where it inhibits 
complex -1of the electron transport chain.This subsequently leads to a decrease 
in ATP production.This increased AMP/ATP ratio inhibits Fructose 1,6 
biphosphatase ,the regulatory enzyme of gluconeogenesis and results in decrease 
in hepatic gluconeogenesis.Further the energy pathways utilizing ATP get shut-
down resulting in decreased glucose,protein,lipid synthesis and increase in fatty 
acid oxidation and glucose utilization.Metformin also regulates the expression of 
key genes involved in gluconeogenesis (SHP,KLF-15,TORC-2,CBP) through 
activation of AMPK resulting in long term suppression of hepatic glucose 
production.Metformin causes down regulation of the sterol response  
element binding protein (SREBP) thereby decreases lipogenesis.28 
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Metformin reduces fasting plasma glucose and insulin levels, improves 
the lipid profile, and promotes modest weight loss. Metformin is administered 
orally and undergoes dose dependant absorption.Its oral bio-availability is 50 to 
60% with a serum half life of 1.5 to 3 hours. Metformin does not undergo 
hepatic metabolism and excreted unchanged by kidneys. The initial starting dose 
of 500 mg once or twice a day can be increased to 1000mg b.i.d. Fewer gastro 
intestinal side effects like diarrhea, anorexia, nausea, metallic taste occur due to 
metformin intake. Metformin is effective as monotherapy and can be used in 
combination with other oral antidiabetic agents or with insulin. The major 
toxicity of metformin, lactic acidosis is very rare.It also causes Vitamin B12 
deficiency. Metformin should not be used in patients with renal insufficiency 
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[GFR < 60 ml/min], any form of acidosis, congestive cardiac failure, liver 
disease, or severe hypoxemia. 
 
Vitamin D Deficiency  
 
                      Vitamin D deficiency is pandemic, yet it is one of the most under-
diagnosed and under-treated nutritional deficiency8 in the world. Vitamin D 
deficiency is widespread in individuals irrespective of their age, gender, race and 
geography. Vitamin D is photosynthesized in the skin on exposure to UVB rays. 
9
 Sun exposure alone ought to suffice for vitamin D sufficiency. However, 
vitamin D deficiency is widely prevalent despite plentiful sunshine even in 
tropical countries like India. 
                      Vitamin D deficiency has a bearing not only on skeletal but also on 
extra skeletal diseases.9 Owing to its multifarious implications on health, the 
epidemic of vitamin D deficiency in India is likely to significantly contribute to 
the enormous burden on the healthcare system of India.10 Cultural and social 
taboos often dictate lifestyle patterns such as clothing that may limit sun 
exposure and vegetarianism which certainly limits vitamin D rich dietary 
options. 
  The socioeconomically backward people constitute a large percentage of 
the population in India. The underprivileged generally suffer from overall poor 
nutrition. Vitamin D rich dietary sources are limited and unaffordable to most 
Indians. Vitamin D supplements are available, but most Indians are not aware 
that they need additional vitamin D.  
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       Additionally, the cost of these supplements is essentially prohibitive 
to the majority. Fortification of staple foods with vitamin D may prove to be a 
more viable solution towards attaining vitamin D sufficiency in India. 
         There are scores of research papers in the literature reporting poor 
vitamin D status from all over India and some from other countries of the Indian 
subcontinent too. Many of these studies measured serum 25-hydroxyvitamin D 
levels in ostensibly healthy subjects. Biochemical evidences of suboptimal bone 
health are elevated alkaline phosphatase (ALP) and elevated PTH levels 
(secondary hyperparathyroidism or SHPT). These were often reported in 
research papers, especially with respect to their correlation with vitamin D 
status. However, the most accurate and convincing measure of bone mineral 
density (BMD) is DEXA (Dual Energy X-ray Absorptiometry).  
           Research articles reporting BMD, as measured by DEXA, in the 
context of vitamin D status of ostensibly healthy individuals, are few. BMD 
data, as they correlated with the vitamin D status in ostensibly healthy Indians is 
compiled. A few articles also reported results of interventions studies such as 
vitamin D supplementation and vitamin D fortified foods.11  
         Mounting evidence suggests that vitamin D deficiency could be 
linked to several chronic diseases, including cardiovascular disease and 
malignancies.12 Vitamin D is produced endogenously when the skin is exposed 
to sunlight and can be obtained exogenously from a few natural food sources, 
from food fortification and from supplements. Simple exposure to sunlight is 
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thought to provide most of the vitamin D 13 requirement of the human 
population. However, skin synthesis of vitamin D may not compensate for the 
low nutritional intake in India, even in countries with high supplies from food 
fortification and supplements. For assessment of vitamin D nutritional status the 
concentration of 25-hydroxyvitamin D (25(OH)D) in serum is considered to be 
an accurate integrative measure reflecting an individual's dietary intake and 
cutaneous production.14 A substantial percentage of the elderly and adolescents 
have a low concentration of 25(OH)D; in the elderly this percentage ranges were 
less.  
       Low vitamin D status seems to be aggravated by disease and 
immobility, and by a low frequency of supplement use. Adequate vitamin D(3) 
by synthesis in the skin or from dietary and supplemental sources is essential for 
bone health throughout life. Vitamin D deficiency is defined as a 25(OH)D 
concentration <20 ng/mL (50 nmol/L); vitamin D sufficiency as a 25(OH)D >30 
ng/mL (75 nmol/L),15 and insufficiency as 21-29 ng/mL. Vitamin D deficiency 
and insufficiency has been linked to a wide variety of chronic diseases including 
common cancers, autoimmune, cardiovascular, and infectious diseases. 
Healthcare professionals need to be aware of the vitamin D deficiency pandemic. 
Guidelines for sensible sun exposure and supplemental vitamin D of 800-1000 
IU/day are needed. 
  In most cases, vitamin D deficiency occurs when individuals do 
not get enough exposure to sunlight and do not take foods that are rich in 
vitamin D.13 Vitamin D deficiency is a global problem and it is known as an 
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essential factor involved in different immune functions besides skeletal and 
muscle development .A recent study reported that most of the nonspecific 
etiologies of common symptoms can result from vitamin D deficiency; although 
some researchers emphasized that more studies need to be done to prove that 
vitamin D deficiency can lead to common symptoms of unknown etiologies such 
as headache and fatigue.14 Another study found that the prevalence of non-
specific muscle pains among the population might result from vitamin D 
deficiency. 
  Vitamin D deficiency has been defined differently from country to 
country. Some consider people are at risk of vitamin D deficiency at serum 
25(OH) D concentrations <30 nmol/L.15 Others define vitamin D deficiency 
based on 50 nmol/L16 as the lowest acceptable value for serum 25(OH) D 
concentrations. The recommended dietary allowance (RDA) is 600 international 
units (IU) (15 mcg) per day for children and adults from 9 to 70 years old and 
the tolerable upper intake level for the same age group is 4000 IU (100 mcg).  
  To avoid any adverse health effect of taking vitamin D above the 
tolerable upper intake, total vitamin D intake should remain below the intake 
level. India is a vast tropical country extending from 8.4º N latitude to 37.6° N 
latitude. Majority of its population lives in areas receiving ample sunlight 
throughout the year and hence there was disbelief that Vitamin D (Vit D) 
deficiency is uncommon in India. However from the data available in the 
published literature, Vit D deficiency is very common in India in all the age 
groups and both sexes across the country.  
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  The causes of vitamin D deficiency among the Indian population 
remain uncertain, as well as the factors that may increase their risk for low 
vitamin D. Studies indicate that lack of sun exposure among population results 
from cultural practices such as conservative clothing and use of completely 
covered dresses, in addition to their lifestyle habit of spending most time 
indoors. Women have higher rates of vitamin D deficiency than men. The level 
of serum vitamin D is low and it is not varied during the year from season to 
season in most people due to some common reasons such as skin pigmentation, 
limited sun exposure and low intake of vitamin D food sources. 
  A study done on vitamin D status in a multi-ethnic population 
found that 83% of the Middle Eastern population and some ethnic groups such 
as Africans and South Asians15 have low serum vitamin D level. There are 
increased rates from  30 nmol/L to 12 nmol/L of vitamin D deficiencies in girls 
wearing conservative clothes in comparison with females living in suburban and 
urban areas. The prevalence of a lower level of serum vitamin D (<25 nmol/L) is 
most common in India and other developing countries, darker skin pigmentation, 
limited sun exposure, higher latitude and lack of foods fortified with vitamin D.9  
  In different countries, the lack of governmental regulations for 
recommended food fortification with vitamin D is one of the most prevalent 
barriers20 to achieve desirable levels of serum vitamin D. Further studies in this 
area could be the next step to highlight the importance of increasing the number 
of foods fortified with vitamin D based on population need. As well, raising the 
public consciousness on sun exposure as a significant source of vitamin D 
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besides the natural food sources is highly recommended. Recent studies point 
out that serum vitamin D levels are improved in North America and Europe; 
however, vitamin D deficiency continues to be prevalent in many regions of the 
Asian countries including India. As a result, this population is at risk of many 
vitamin D-related diseases and this is one of reasons for conductance of this 
study.  
      More studies need to be done on vitamin D deficiency among the 
Indian population with diabetes mellitus. Most of the literature reviews have 
indicated that the severity of vitamin D deficiency in this population which can 
lead to serious implications for the growth of future generations and the overall 
health of the community. 
 
Vitamin D – an overview 
       Vitamin D is important to facilitate calcium absorption and it has an 
essential role in maintaining bone and skeletal health. Serum 25-hydroxyvitamin 
D [25(OH) D] is the measurement variable for vitamin D status. The human 
body can obtain vitamin D through exposure to sunlight, from diet and dietary 
supplements. Vitamin D from the sunshine and diet is metabolized within 3 days 
by the liver into 25(OH) D, which is used to determine a patient’s vitamin D 
status. 
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Vitamin D is converted from 7-dehydrocholesterol to 25-hydroxyvitamin 
D3 when it is transported to the liver by a binding protein; 25-hydroxyvitamin D 
is further converted to 1, 25(OH) 2D in the kidney as the final step in the 
activation of vitamin D. When there is not enough sun exposure, serum 25-
hydroxyvitamin D decreases gradually, with a half-life of at least 2 months. The 
maximum number of days for serum levels of the [25(OH) D] metabolite after 
getting the highest sun exposure in the summer is about 30 – 60 days.  
 
Vitamin D from Sun 
 Skin exposure to solar UV-B radiation is a significant source of vitamin 
D. For example, someone exposed to the sun wearing only a bathing suit will get 
vitamin D2 equivalent to the ingestion of approximately 20,000 IU. Because of 
the shorter atmospheric distance between the earth’s surface and the sun (which 
is directly above the Equator) and the ozone layer being naturally thinner in 
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areas close to the Equator (which make it easy to absorb UV radiation), the 
geographic regions around the Equator which include Middle Eastern countries 
have the greatest UV rays. Moreover, seasons contribute essentially to vitamin D 
deficiency in all populations.  
  A higher rate of vitamin D deficiency occurs during winter and spring, 
even if people in the Middle Eastern countries and other areas are taking vitamin 
D supplements because of the positioning of the sun’s rays as it hits the earth, 
which can affect “both quantity and quality of solar radiation reaching the earth's 
surface”. However, some studies done at low latitude areas e.g. 24 N° show a 
prevalence of low vitamin D. In addition, obesity (because of the possible 
sequestration of vitamin D in body fat) and darker skin in Saudi Arabia are 
common factors that increase the time required for sun exposure to get the ideal 
vitamin D level. 
   The enhanced fat solubility and decreased bioavailability of vitamin D 
produces low serum vitamin D levels with obesity. Exposing the skin to sunlight 
to absorb vitamin D is a major factor in increasing the body’s circulating serum 
vitamin D. In addition, there are different factors that affect the amount of 
vitamin D synthesized by the skin through sunlight exposure such as individual, 
geographical and seasonal variations . Risk of common skin cancers is decreased 
when serum vitamin D is around 75 nmol/L. Risk of skin cancer is one of the 
barriers to sun exposure. However, too much sun may result in sunburn and 
damage the skin, which may lead to skin cancer. If a person is going to be 
exposed to the sun for a long time, it is better to use sunscreen protection.  
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Vitamin D in Food 
Not too many foods are considered good natural sources of vitamin D. 
For example, fatty fish, eggs, organ meats and UV-irradiated mushrooms are 
some of the main sources of vitamin D. 
 In addition, in Saudi Arabia fortified foods are limited to very few dairy 
products and cereals.22 The Middle Eastern countries are poor in food 
fortification in general and in vitamin D specifically. Only wheat flour 
fortification is mandatory in terms of legislation in most of the Middle Eastern 
countries.  
In Canada, there are more foods that fortified with vitamin D compared to 
the Middle Eastern countries. Examples of foods fortified with vitamin D in 
Canada are orange juice, grain products, soy beverage, eggs, some meat and 
alternatives, and some fats and oils. 
 
Vitamin D from Supplements  
Dietary supplements are one source of vitamin D. There are different 
kinds of supplementation such as over-the-counter and prescription supplements. 
In some cases, use of supplements is needed to fulfill the body’s vitamin D 
requirement. A study reported that after one year of vitamin D supplementation, 
there is evidence of increased leanmass, bone area, and bone mass.Positive 
outcomes with vitamin D supplementation were significant for patients with 
chronic diseases along with vitamin D deficiency. More studies are needed in 
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this area to determine the role of vitamin D supplementation- on overall health 
outcomes. With severe vitamin D deficiency; vitamin D supplementation may 
help to improve vitamin D serum level as shown among study participants where 
their serum vitamin D level was elevated to sufficient range. In another study, 
exceeding the upper intake level of vitamin D may have resulted in 
hypercalcemia, hypercalciuria, and hyperphosphatemia. 
The recommended dietary allowance (RDA) for vitamin D is 600 
international units (IU) (15 mcg) per day for children and adults 9 to 70 years 
old and for the same age group the tolerable upper intake level (UL) is 4000 IU 
(100 mcg). 
 
Vitamin D metabolism 
Vitamin D can be synthesized in sufficient amounts by most vertebrates 
on adequate exposure of the skin to sunlight (UVB rays). It is critical that most 
vertebrates obtain a sufficient amount of vitamin D either from their diet or from 
adequate exposure of the skin to sunlight. The term vitamin D refers to 
compounds vitamin D3 (cholecalciferol) or vitamin D2 (ergocalciferol). Vitamin 
D3 is produced in the skin on exposure to sunlight. Vitamin D3 is derived from 
7-dehydrocholesterol by ultraviolet irradiation of the skin. Vitamin D3 is also 
found in animal food sources e.g., fatty fish (e.g., salmon, mackerel and tuna) 
cod liver oil, milk, etc. Vitamin D2 is found in vegetal sources like sun-exposed 
yeast and mushrooms. Notably, most dietary sources are not sufficiently rich in 
their vitamin D content. Vitamin D (both forms D3 or D2) is a prohormone 
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which requires two hydroxylations to finally attain its biologically active form -
1,25(OH)2D. The first hydroxylation occurs in the liver, at position 
 
 
 
C25 to form 25-hydroxyvitamin D, also known as 25(OH)D or calcidiol. 
Previously considered to be inert, 25(OH)D is the major circulating and more 
active  form of vitamin D.It is an indicator of serum vitamin D status. The 
second hydroxylation occurs at position C1α to form 1,25(OH)2D, also known 
as calcitriol 1,25(OH)2D is produced primarily but not exclusively in the 
kidneys. Both 25(OH)D and  1,25(OH)2D  are released in blood, where they 
binds to vitamin D binding protein (DBP) and reaches its target tissues to exert 
its endocrine functions through the vitamin D receptor (VDR). 1,25(OH)2D is 
also produced in several extrarenal tissues for its paracrine and autocrine 
functions. Most cells in the body have VDR. Both metabolites of vitamin D are 
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capable of regulating a wide variety of genes that have important functions in 
regulating cell growth and differentiation. 
 
Vitamin D and Skeletal Health 
Vitamin D is a hormone of skeletal integrity13. Rickets, osteomalacia and 
osteoporosis23, 24 are widely prevalent all over the world. The most well 
recognized function of 25(OH)D involves regulation of calcium and phosphorus 
balance for bone mineralization and re modeling. Without adequate levels 
of25(OH) D  in the bloodstream, dietary calcium cannot be absorbed. Low 
calcium levels lead to an increase in serum PTH concentration, which leads to 
increased tubular reclamation of calcium in kidneys and resorption from the 
skeleton at the cost of lowering bone density. In the long term this leads to 
weakened and brittle bones that break easily. Approximately 40%–60% of total 
skeletal mass at maturity is accumulated during childhood and adolescence. 
Rickets results from inadequate mineralization of growing bone. Thus it is a 
childhood disease and it is manifested as bone deformities, bone pain and 
weakness. Biochemical abnormalities consistently include hypophosphatemia, 
elevated alkaline phophatase levels and serum 25(OH)D levels are usually below 
5 ng/mL. Chronic vitamin D deficiency in adults results in osteomalacia, 
osteoporosis, muscle weakness and increased risk of falls..      Epidemiological 
support for skeketal benefits of vitamin D is well known 
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Vitamin D: Extraskeletal Effects 
Biochemical studies have implicated vitamin D deficiency in many 
chronic diseases including, but not limited to, infectious diseases, autoimmune 
diseases, cardiovascular9 diseases, diabetes, gestational diabetes mellitus8 and 
malignancies. Numerous epidemiological publications support the extraskeletal 
benefits of vitamin D and they cannot be ignored even though majority of these 
are association studies or small randomized controlled trials. Nevertheless, 
stronger evidence is required with the aid of more robust and reliable statistical 
methods such as randomized controlled trials (RCTs). These RCTs should be 
well-designed, well-executed and conducted worldwide to generate dependable 
and incontrovertible data, in order to assess the benefits of vitamin D 
supplementation not only as a preventive measure but also as adjuvant therapies.   
 
Role Of Vitamin D in Diabetes Mellitus 
          The presence of vitamin D receptors (VDR) and binding of vitamin D with 
vitamin D  binding proteins (DBP) in β cells of pancreas facilitates the secretion 
of insulin from pancreatic β cells.Vitamin D promotes pancreatic β-cell function 
in numerous ways29. 
1.Direct actions: Activation of vitamin D occurs in pancreatic β-cells by 
intracellular 1-α-Hydroxylase enzyme.Vitamin D enhances insulin secretion by 
forming 1,25(OH)2D3-RXR-VDR complex which binds to vitamin D responsive 
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elements (VDRE) found in the insulin gene promoter region, enhancing the 
transcriptional activation of the insulin gene and increase insulin synthesis 
 
2.Indirect actions: Insulin secretion is a calcium-dependent process and is 
influenced by calcium influx through the cell membrane. Vitamin D regulates 
calbindin, a cytosolic calcium-binding protein found in β-cells. It acts as a 
modulator of depolarization-stimulated insulin release via regulation of 
intracellular calcium. Decreased intracellular calcium level  in insulin target 
tissues may contribute to peripheral insulin resistance via impaired signal 
transduction pathways leading to decreased glucose transporter activity. Vitamin 
D promotes increased calcium influx into the cells, leading to increased transport 
of glucose into the muscle   
3.Vitamin D enhances insulin sensitivity by stimulating the expression of 
insulin receptor (INS-R) and/or by activating peroxisome proliferator-activated 
receptor-δ (PPAR- δ) implicated in the regulation of fatty acid metabolism in 
skeletal muscles and adipose tissue.  
. 
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         Further vitamin D receptor gene polymorphisms (FokI BsmI,TaqI) is 
associated with increased risk of T2DM.30 
 
Cardiovascular Health 
Cardiovascular diseases (CVDs), including congestive heart failure and 
coronary artery diseases19 are a major cause of morbidity and mortality 
worldwide. There is accumulating epidemiological evidence from observational 
studies suggesting that CVDs are associated with vitamin D deficiency20. 
Increased risk of hypertension was associated with people living at higher 
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latitudes.25(OH)D level < 21 ng/mL was associated with increased risk of 
hypertension, diabetes, obesity and high triglyceride levels—all associated with 
increased cardiovascular mortality. Various studies have reported reduced 
25(OH)D concentrations in patients with previous and prevalent cardiovascular 
or cerebrovascular diseases. 
 
Immunity 
As early as in the 19th century, cod liver oil (a rich source of vitamin D) 
was used for treating tuberculosis (TB). Skin exposure to sunlight was an 
effective therapy for treating Mycobacterium infections of the skin. In 1903, 
Finsen received the Nobel Prize for demonstrating that Lupus vulgaris, the 
epidermal form of TB, could be cured using light from an electric arc lamp. In 
early 1900s, growing awareness of benefits of sun exposure pertaining treatment 
of infectious diseases led to the development of sanatoriums in sun-rich areas. 
These sanatoriums enabled regimented sun exposure, diet and exercise. These 
sanatoriums primarily hosted TB patients. Recent studies have linked vitamin D 
deficiency with increased risk of developing TB, otitis media, upper respiratory 
tract infections and influenza. 
 
Malignancies 
                 Adults living at higher latitudes are more likely to develop various 
carcinomas including colorectal carcinoma, prostate carcinoma, ovarian 
carcinoma,24 breast carcinoma, lung carcinoma and oesophageal carcinoma30. 
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Retrospective and prospective epidemiologic studies showed that when 
25(OH)D levels were <20 ng/mL there was a 30%–50% increased risk of 
developing and dying of colorectal, prostate, breast, pancreatic, and esophageal 
carcinomas. 
 
Vitamin D Deficiency – Global Distribution  
Estimates of about one billion people are reportedly suffering from 
vitamin D deficiency and it is a widespread problem.Vitamin D deficiency has 
been associated with different chronic diseases, such as rickets in children and 
osteoporosis in adults, because it has an important role in bone metabolism and 
many cellular and immunological processes.The Canadian Health Measures 
Survey reported that vitamin D > 50 nmol/L was considered as a sufficient level 
of serum vitamin D to meet the recommended dietary allowance (RDA), while < 
50 nmol/L was considered insufficient level of serum vitamin D. Serum vitamin 
D <30 nmol/L represents the deficiency level. About 32% of Canadians were 
below the vitamin D cut-off of 50 nmol/L and 10% were considered vitamin D 
deficient (< 30 nmol/L). The national average of serum [25(OH) D] levels was 
64 nmol/L . The best marker of vitamin D stores is serum 25-hydroxyvitamin D 
[25(OH) D]; thus, vitamin D deficiency is diagnosed by measuring serum              
25-hydroxyvitamin D. In addition, vitamin D deficiency can be identified 
through clinical assessment of rickets in children or osteomalacia in adults. 
However, vitamin D deficiency can occur for some time before the bone 
manifestations of the clinical deficiency state present to medical attention.The 
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healthier level of [25(OH) D] is higher than the normal range recommended for 
the population and how the ideal [25(OH) D] levels are defined varies from 
country to country. However, Health Canada stated that people who had serum 
[25(OH) D] < 30 nmol/L are considered at risk of vitamin D deficiency. 
A general perception is that the Middle East is a hot area with adequate 
sunshine. Although there are no fixed boundaries of the region, most 
geographical sites mentioned include countries like Egypt, Bahrain, Iran, Iraq, 
Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, 
Turkey, the United Arab Emirates, and Yemen. Despite the adequacy of 
sunshine, hot weather and arid climate which allow maximum vitamin D 
production in humans (through skin exposed to UVB light for about 5-30 
minutes depending on the time of day, season, latitude, and skin 
sensitivity),there have been many studies that show the population of this area 
being deficient in Vitamin D. Vitamin D has several important physiological 
functions in the human body of all age groups, from infancy to old age. 
Worldwide, it is estimated that almost 1 billion people suffer from Vitamin D 
deficiency. We know that sunlight is a major source, yet the populations of 
countries receiving most of it are estimated to suffer the most, with worst figures 
and prevalence rates. According to a European study, people living in sunny 
countries have more deficiency than other countries because of inadequate 
exposure to sunlight. A study done on Saudi Arabia’s population found that they 
have a high prevalence of vitamin D deficiency at (28nmo/L- 33 nmol/L) in both 
summer and winter seasons and it was even higher in the winter season. 
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Researchers have surmised that vitamin D deficiency among Saudi women can 
result from a lack of public awareness. However, post-menopausal women had 
high serum vitamin D levels in the study among Saudi female outpatients while 
another study on healthy Saudi women has the opposite. The study on Saudi 
female outpatients as study groups had higher serum vitamin D levels possibly 
because many clinicians tend to routinely recommend calcium and vitamin D 
supplements to post-menopausal women, without measuring their vitamin D 
status, as a protection against osteoporosis. 
 
Testing Vitamin D Status 
Plasma 25(OH)D or calcidiolis the most reliable marker of vitamin D 
status. Immunoassays such as radioimmunoassay (RIA), enzyme linked 
immunosorbant assay (ELISA), chemiluminescence immunoassay and protein 
binding assays are used in routine testing of 25(OH)D in clinical laboratories. 
LCTMS (liquid chromatography tandem mass spectrometry) is the widely 
accepted reference method for 25(OH)D measurement. However, LCTMS is 
tedious, expensive and time consuming and therefore seldom used 
commercially. Since vitamin D under nutrition is largely silent and subclincal, 
the indication for testing remains controversial. At present 25(OH)D test is the 
“most ordered test” in the USA. A similar trend has just begun in the upper 
socioeconomic stratum in India too. This clearly shows increasing awareness 
pertaining widespread prevalence of vitamin D deficiency among Indian 
clinicians. A 25(OH)D test using antibody based technologies in India costs an 
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individual approximately INR 1500, which is unaffordable for most Indians. 
Surely, vitamin D status needs to be improved in most individuals in India and 
not just the privileged or a select few. However, testing every individual’s 
vitamin D levels, in a population with such a high prevalence of vitamin D 
deficiency is not economically and practically feasible. Furthermore, whether 
subclinical vitamin D deficiency in otherwise healthy individuals should be 
treated or not, and to what target level of serum 25(OH)D remains controversial. 
It will be more cost-effective to implement aggressive nationwide vitamin D 
supplementation and food fortification programs for the benefit of all ostensibly 
healthy individuals. 
 
Health Problems Associated with Vitamin D Deficiency 
 People who are suffering from severe serum vitamin D deficiency 
experience some symptoms of numbness, paresthesia (abnormal or impaired skin 
sensation), muscle cramps, laryngospasm, tetany and seizures, while those with 
minor deficiency may complain from having muscle weakness or pain. In 
addition, a deficiency may cause rickets, osteomalacia, osteoporosis, multiple 
fractures, and growth retardation. 
 Another study found that low bone mineral density in adults is strongly 
associated with low serum 25-hydroxyvitamin D level  and low serum vitamin D 
leads to reduced ability to absorb calcium. In pregnant women, low vitamin D 
can be noticeable in the fetal skeleton during the 19th week of pregnancy. In 
some cases low serum 25-hydroxyvitamin D levels is associated with colon 
30 
 
cancer mortality. A study done on the American population showed that vitamin 
D insufficiency/deficiency is associated with cardiovascular disease deaths. 
Vitamin D is also important for some of the metabolic syndromes such as 
hypertension, obesity insulin resistance and glucose intolerance. Other studies 
show that vitamin D deficiency is associated with several chronic diseases such 
as cancer, infection asthma, and dermatopathies (skin problems of unknown 
etiologies), insulin resistance, diabetes and related microvascular complications 
and retinopathy. Vitamin D insufficiency can cause calcium malabsorption and 
secondary hyperparathyroidism. Multiparity and menopause also seem to be 
statistically associated with hypovitaminosis D.Obesity has indirect effects on 
physical activity by decreasing movement and as a result, sun exposure may be 
restricted which will decrease vitamin D levels. Recent studies found that 
vitamin D deficiency is also associated with autoimmune disorders, CVD and 
cancers. 
 
Vitamin D Status of Ostensibly Healthy Indians 
 Countrywide studies have reported vitamin D deficiency in as high as 
70%–100% of ostensibly healthy individuals. High prevalence of vitamin D 
deficiency was reported from northern to southern and western to eastern India, 
in ostensibly healthy children, adolescents, young adults and those ≥50 years 
old. All over India, vitamin D deficiency was highly prevalent in pregnant 
women and lactating mothers. Vitamin D status of these mothers correlated well 
with their neonates and their exclusively breastfed infants. Subjects from rural 
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and urban areas presented a similar picture. Relatively, fish are a rich source of 
vitamin D. The residents of Bengal (eastern India) eat more fish compared to the 
rest of the Indians. Surprisingly, their vitamin D status appears to be just as poor 
as in the rest of the country. Similarly, even healthy young soldiers with 
sufficient intake of calcium, adequate sun exposure and regular exercise regimen 
were found to be vitamin D deficient  as were young sportswomen. Among 
resident doctors from Mumbai (western India) and also doctors from eastern 
India, most were vitamin D deficient. Vitamin D deficiency was also observed in 
most of 2119 healthcare professionals studied from all over India.Evidently, 
countrywide prevalence of vitamin D deficiency is undeniable. 
 
Correlation of Vitamin D Status with Bone Health of Ostensibly Healthy 
Adolescents and Adults in India 
 Among otherwise healthy adolescents and adults studied, along with low 
serum 25(OH)D levels, a significant number of subjects also revealed other 
biochemical and clinical manifestations of vitamin D deficiency. Biochemical 
evidences of suboptimal bone health are: elevated alkaline phosphatase, a 
surrogate marker for increased bone turnover, and elevated PTH levels 
(secondary hyperparathyroidism or SHPT). ALP and PTH were often reported in 
research papers, especially with respect to their correlation with vitamin D 
status. However, the most accurate and convincing evidence of bone density is 
DEXA. Only research articles reporting BMD, as measured by DEXA, in the 
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context of vitamin D status of ostensibly healthy individuals are observed in 
various studies. 
 Vitamin D intervention studies that measured resultant BMD outcomes 
are reviewed discussed. Most studies did not show any correlation of BMD with 
vitamin D status. Notably, among 90 adults, who were 20–30 year-old soldiers 
from Indian paramilitary forces, with adequate nutrition, sun exposure and 
physical exercise, BMD was lower when compared to Caucasians. Among men, 
osteopenia was noted in 50% at the lumbar spine, 35% at the hip, and 50% at the 
forearm. 
 Additionally, 10% of men had osteoporosis of the lumbar spine. Among 
women, osteopenia was noted in 32% at the lumbar spine, 14% at the hip and 
21% at the forearm. The authors speculated that the effect of childhood 
malnutrition may have contributed to lower peak bone mass accumulation in 
these subjects. BMD studies emphatically underline the need for adequate 
nutrition, sun exposure and physical exercise from the very beginning of one’s 
life, to attain peak bone mass, and later to maintain it. Indubitably, vitamin D 
status in India is grim and needs to be reckoned with. 
 
Vitamin D Sufficiency via Sun Exposure Is Not a Tenable Solution for Most 
Indians 
 Vitamin D deficiency is a major health concern in India, notwithstanding 
the brightly shining sun. The adequacy of exposure to sunlight of an individual’s 
bare skin required to photosynthesize vitamin D is grossly ill understood. Darker 
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skin has high melanin content which acts as a natural sunscreen. Therefore, 
darker skin produces a significantly lesser amount of vitamin D when compared 
with the individuals with fairer skin, such as Caucasians.Thus, for Indian skin 
tone, minimum direct sun exposure required daily is more than 45 min to bare 
face, arms and legs to sun’s UV rays (wavelength 290–310 nm). With the 
exception of those who perforce need to work outdoors in the sun, most Indians 
do not get adequate sun exposure to produce sufficient amounts of vitamin D 
endogenously. Indian social and or religious norms related to public modesty 
dictate that most parts of an individual’s body, irrespective of gender, be 
covered. The not so D-lightful price of urbanization in big cities a majority of 
people live in very high population density areas. They perforce live in 
overcrowded tenements, which are closely packed and 3–4 stories high. 
Consequently, direct sunlight does not reach inside most parts of the dwellings, 
thereby disallowing any sun exposure to an individual in the privacy of one’s 
home. Additionally, lack of space offers limited options for outdoor activities. 
Atmospheric pollution of metropolitan India also factors in with respect to 
vitamin D status. 
  The extreme discomfort of the scorching heat associated with most sunny 
days of Indian summer instantly extinguish any desire for sun exposure and a 
person’s primary focus is on finding ways to avoid the sun, at all costs. Usage of 
sun screen lotion aggravates the existing status. Therefore, in the Indian 
scenario, vitamin D sufficiency cannot be attained by depending on adequate sun 
exposure.  
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Nutritional Factors Attributing to High Prevalence of Vitamin D Deficiency 
in India 
 Vitamin D sufficiency by dietary intake is the only tenable solution for 
Indians. However, this solution itself has a barrage of problems. Most dietary 
sources of vitamin D have very low vitamin D content. Most of the food items 
rich in vitamin D are of animal origin. Commonly, a dietary source of vitamin D 
for vegetarians is milk, provided milk has been fortified with vitamin D. Milk is 
rarely fortified with vitamin D in India. The vitamin D content of unfortified 
milk is very low (2 IU/100 mL). Additionally, milk and milk products are 
unaffordable to the socioeconomically underprivileged. Another concern in India 
is the rampant dilution and/or adulteration of milk and milk products. 
 Low dietary intake of calcium in conjunction with vitamin D 
insufficiency is associated with secondary hyperparathyroidism (SHPT). SHPT 
is further exacerbated by induced destruction of 25(OH)D and 1,25(OH)2D by 
24 hydroxylase [64]. 24 hydroxylase is the key enzyme of vitamin D catabolism 
and is regulated by 1,25(OH)2D, PTH and FGF23 (Fibroblast Growth Factor 23) 
levels. FGF23 is a phosphate regulator. High serum phosphate levels increase 
production of FGF23 in bone osteocytes via the action of 1,25(OH)2D. 
Subsequently, FGF23 reduces renal phosphate resorption, indirectly suppresses 
intestinal phosphate absorption and also suppresses PTH and 1,25(OH)2D 
synthesis. Overproduction of FGF23 can result in increased morbidity associated 
with vitamin D deficiency.This regulatory mechanism may explain the low 
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25(OH)D levels in rural subjects on a high phytate and/or low calcium diet, 
despite plentiful sun exposure. Most studies reported calcium intake much lower 
than the RDA (Recommended Daily Allowance) defined by the Indian Council 
of Medical Research (ICMR). Only two studies reported adequate calcium 
intake. In both these publications the study subjects were paramilitary soldiers. 
ICMR’s RDA for calcium intake in India is lower than that of the western world. 
 Calcium balance is a function of intake and excretion.Even though the 
Indian diet is low in calcium content, it also has a lower protein content and 
therefore low endogenous acid production, which may reduce urinary calcium 
loss. Therefore, the amount of dietary calcium required to maintain calcium 
balance may be lower than for those in the Occident. The protein-induced 
alterations in calcium homeostasis (and possibly in bone mass) have been 
attributed to increments in endogenous acid production and net acid excretion 
due to the oxidation of the constituent sulfur containing amino acids. On the 
other hand, the high salt content of Indian diet is likely to increase urinary 
calcium excretion. A direct relation between high sodium intake and lower bone 
mass has been reported. 
 Intake of caffeine from tea and coffee is very high in India. Most Indians 
consume milk as part of their tea or coffee. The proportion of milk is very low in 
these drinks. Thus calcium intake through these beverages is low. Vitamin D is 
stable during cooking. It is stable up to 200°C. However, thermal stability of 
vitamin D is an inverse function of both temperature and time. In India, milk is 
boiled for several minutes before consumption. Before the same lot of milk is 
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consumed in entirety, it is subjected to two-three rounds of boiling. In India, 
most of the times, beverages like tea and coffee are boiled for several minutes to 
get the right flavor. This boiling may reduce the content of any vitamin D that 
there may have been left after boiling of the milk itself. Therefore, these 
beverages may not contribute significantly to either calcium or vitamin D intake 
in Indians. Vitamin D is a fairly robust vitamin. The preceding statements about 
its thermal degradation have been made as precautionary stance to not overstate 
the thermal robustness of this micronutrient. Additionally, studies have reported 
association of high caffeine intake with increased risk of low bone mineral 
density, osteoporosis, and osteoporotic fractures in middle-aged women. This 
situation is exacerbated in women with low calcium intake, especially in lean 
subjects. 
 High prevalence of lactose intolerance in India is a major deterrent 
pertaining milk consumption, further lowering intake of calcium and vitamin D 
in these individuals. Ethnic and geographic variations of lactose intolerance were 
observed, with a higher prevalence in southern and eastern India compared to 
northern India.  
Indian diet has high phytate content. Phytate is the principal storage form of 
phosphorus in many plant tissues, especially the bran portion of grains and other 
seeds. Phytate is indigestible to humans. Phytates chelate micronutrients such as 
calcium and iron, and thus reduce intestinal absorption of these nutrients. 
Benefits of sun exposure in rural subjects owing to an agrarian life were seen by 
significantly higher 25(OH)D levels. However, possibly owing to high phytate 
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content in diet, these levels were still insufficient in most individuals. Possibly, 
high phytate content in the diet of soldiers in northern India may have 
contributed to their vitamin D insufficiency, despite adequate sun exposure, 
nutrition and physical exercise. 
  Dietary habits in India have changed significantly. Many people remove 
a substantial proportion of bran from whole wheat flour before kneading to 
improve texture and fluffiness of chapatis(unleavened flat bread). Consumption 
of white bread is also very high. Most people prefer processed, split and polished 
pulses to whole seeds due to the ease of shorter time required for cooking and 
the consequent lowered expense of cooking fuel. Consumption of instant (or not) 
noodles and burgers also is on the rise across all socio-economic strata, with the 
exception of the impecunious. 
 High phytate in Indian diet especially among th socio-economically lower 
classes stems from the elementary and immediate need of sufficiency of the 
calorific need. Cereals and legumes are more affordable and easily available than 
vegetables, milk and other dairy products. Besides, they are sources of protein 
for the vegetarians. Many cereals are also sources of calcium, however due to 
chelation by phytates its bioavailability is limited. 
 In the scenario of inadequate calcium intake, vitamin D insufficiency and 
high phytate content in diet, environmental pollutants such as fluoride add insult 
to injury. Toxins like fluoride affect bone metabolism severely in the 
conjunction with inadequate calcium intake, especially in children. 
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 Indians in general adhere to traditional cooking styles and practices, 
irrespective of their migration to any part of the world. In tropical climate 
perishable food items putrefy quickly. Notably, in India there is no perceptible 
government regulation on the hygiene and microbial quality control of fresh 
produce that reaches from the producer to the end-consumer. Consumption of 
uncooked fresh produce, especially vegetables, milk, etc., is generally 
considered ill-advised. As in the rest of the world, in India too, slow cooking is 
widely practiced. This culinary practice, however, is ill-advised bearing in mind 
the thermal instability of many vitamins. Its thermal stability is inversely related 
to temperature and time. Cooking gas flame reaches temperature above 1900°C 
and coal stove heat reaches 300–700°C. Water boils at 100°C. 
 Baking is done mostly above 175°C but the temperature in the food does 
not reach such high temperatures, therefore stability of vitamin D during baking 
is well within acceptable range. Pertaining shallow and deep-frying of food, 
most cooking fats and oils have smoke points above 180°C. Shallow and deep 
frying of foods is very popular in India. When foods are fried, vitamin D in the 
food comes out into the cooking medium and is thermally degraded. 
 Pressure cooking temperatures vary depending on the pressure withstood 
by the cooker used and may range from 100°C to 120°C. Short-time (as short as 
possible) pressure cooking is definitely advisable to retain at least some of the 
thermally more stable essential nutrients in cooked food, including vitamin D.  
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 Protein malnutrition and poor overall nutrition resulting from poverty: 
Perforce, in the sordid context of poverty, focus on a balanced diet is always on 
the back burner. It is very convenient to attribute dietary patterns or cooking 
traditions, than face a reality as grim as poverty. Factually, balanced diet is only 
an occasional treat to the impecunious. An old adage, “When a poor man eats 
chicken, one of them is sick”, says it all. Publications indicating wide prevalence 
of vitamin D deficiency in healthy Indians have studied subjects mostly from 
lower and upper middle classes. Individuals below poverty line were not 
represented well in these studies. Hence, poor nutrition observed in these studies 
may also stem from lack of awareness of the features, benefits and necessity of 
balanced nutrition. 
 
Vitamin D Fortification in USA and Canada 
 Despite predominantly non-vegetarian dietary pattern, approximately 
60% of the intake of vitamin D from food comes from fortified foods in USA 
and Canada. In USA, vitamin D fortification of foods is voluntary, but it is 
strictly regulated pertaining categories of foods, functional use and level of use, 
thus limiting over-fortification. Vitamin D fortified milk has been available in 
USA since the 1930s. Vitamin D is added to most milk sold in the United States, 
although it is not added to all milk products like cheese and ice cream. Some 
manufacturers also add it to cereal, soymilk, rice milk, and orange juice, usually 
along with calcium. In USA either form, D2 or D3, may be used for fortification, 
but commonly D3 is used. In Canada, the law mandates fortification of milk, 
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milk alternatives and margarine. Similar to USA, for other permitted foods, 
vitamin D fortification D is voluntary, but fortification level is limited. 
 
Statistics on Vitamin D Deficiency in Middle East Countries 
 In countries that have similar cultural practices and lifestyle habits outside 
of the Middle Eastern countries such as Tunisia, the prevalence of vitamin D 
deficiency was 47.6% and the deficiency increased with age. Those in the age 
group between 50-59 years have a deficiency of about 59.5% while those in the 
age group between 20-29 years have less deficiency of about 35.8%. In addition, 
the severe deficiency level of serum vitamin D was 12.5 nmol/L and it is 
commonly prevalent among a certain group of women. 
 About 70.5% of veiled women had the deficiency, which is higher than 
that of unveiled women at 48.9%.However, vitamin D deficiency is infrequent in 
the United States and Japan. In Japan, 7.9% of the study participants have low 
levels of vitamin D; while 14.5% women in the United States study have 
hypovitaminosis D lower than 37.5 nmol/L. In the United States, more foods are 
fortified with vitamin D compared to Europe. In Canada, 10% of Canadians 
were considered as being vitamin D deficient (< 30 nmol/L). 
 Many of the young and aging people in the Middle East suffer from 
hypovitaminosis D. A study done in Lebanon showed that 41% have severe 
deficiency, levels lower than serum 12.5 nmol/L. About 84% of young females 
had serum vitamin D levels lower than 30 nmol/L .The Gulf region (Bahrain, 
Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates, Iran, Iraq) has a 
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prevalence of insufficiency and deficiency of serum vitamin D at levels of 
25(OH) D < 30ng/mL (< 74 nmol/L). 
  The National Academy of Sciences Institute of Medicine advocates for a 
daily intake of 400 to 600 IU/day for adults 18 to 70 years old and 400 to 800 
IU/day for those older than 70 years. The American Association of Clinical 
Endocrinologists recommends a higher intake of 1000 to 2000 IU/day to reach a 
target vitamin D serum concentration of 30 to 50ng/mL. Another study showed 
that 70% of Iran’s and 80% of Saudi Arabia’s populations have low serum 
vitamin D levels. Another study done about vitamin D deficiency in the Middle 
East showed that Emirati (UAE) women have more vitamin D deficiency than 
western women living in UAE. About 83 % of Saudi women who have low 
levels of vitamin D have been reported to also have back pain. 
 
Sunning Practices 
 Vitamin D deficiency is a widespread disease in many countries around 
the world in different age groups such as North America, Europe and the Middle 
East. Despite the high latitude and long sunlight hours in the Middle Eastern 
countries, lack of sunlight exposure is the major cause of vitamin D deficiency 
among the populations. Young male athletes have normal vitamin D levels 
especially those who spend most of their sport practice outdoors although 
athletes are still at risk of vitamin D deficiency. 
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 One of the studies among Saudis report a lack of sun exposure with only 
6 male participants out of 200 participants exposing themselves to sunlight for 
vitamin D from the sun.Lack of sun exposure was also reported as one of the 
most important predictors of hypovitaminosis D in developing countries 
.Another study on vitamin D deficiency among Saudi married couples reported 
that males were significantly exposing themselves to sunlight more than their 
female partners. Lack of sun exposure is also one of the common results of 
sedentary lifestyle in the Gulf region. In addition, sun exposure is greatly 
affected by clothing style that covers most of the body, which leads to reduced 
vitamin D production in the skin Thus, limited sun exposure in the Middle East 
appears to be mostly due to cultural practices, clothing styles and limited 
outdoor activity.  
 
Food Habits 
 Dietary factors have an important role in vitamin D deficiency among the 
Middle Eastern populations. Their intake of foods rich in vitamin D is limited 
and this has been shown as one of the main risk factors of vitamin D deficiency. 
There is also a lack of awareness in Delhi (India) on the value of taking vitamin 
D supplements. Lack of food and dairy products fortified with vitamin D is a 
problem in many countries of the Middle East. For example, in Saudi Arabia, the 
Saudi Ministry of Health is trying to change this by increasing milk fortification.  
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However, the Saudis have low consumption of milk and dairy products 
due to lactose intolerance, and in addition, phytates in bread can limit the 
absorption of calcium in the gut. 
 The food habits in some Middle Eastern regions have changed from 
healthy foods such as dates, milk, fresh vegetables and fruit, whole wheat and 
fish to fast and unhealthy foods such as fried chicken and beef burgers which are 
low in vitamin D. In addition, some Gulf countries rely on importing a lot of 
food to meet their population needs while they export a lot of seafood. People in 
the Gulf countries tend to gather a lot and cook and eat foods at home together, 
which lead to high intakes of calories per day. 
 
Men versus Women 
 Men’s work environment is mostly different than women’s in terms of 
having a lot of time working outdoors, thus exposing themselves to sunlight. 
Most of women have indoor environment workplaces. As a result, women (70%) 
have more deficiency of < 25 nmol/L of serum vitamin D than men (40%).There 
are not enough studies that show the difference between men and women in 
terms of vitamin D deficiency. Some studies considered vitamin D deficiency 
based on gender, but with no actual comparisons between both genders in terms 
of vitamin deficiency and its risk factors.In terms of risk factors affecting 
vitamin D level and controlling for some confounding variables between 
genders, most men were wearing lighter clothing than women; however, there 
were no differences in physical activity, medication intake, and skin colour.  
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Dietary patterns were quite similar between men and women in the study 
of Saudi married couples; however, the intake for both fresh milk and soft drinks 
were higher among men.  
 
Genetic and Epigenetic Factors Affecting Vitamin D Status 
 Genetic factors leading to vitamin D deficiency in Indians, due to their 
effect on expression of genes that modulate vitamin D metabolism may not be 
ruled out. Genetic factors such as polymorphisms in 7 dehydroxylase reductase, 
DBP, 1 alpha hydroxylase, VDR, 25 hydroxylase, 24 hydroxylase have been 
studied. However, a clear association between these polymorphisms and vitamin 
D status is yet to be established. Epigenetic factors too may be important that 
pertain to heritable changes in the gene expression, while the DNA sequence is 
unchanged. These are several possibilities including post-translational 
modifications of histones and methylation, acetylation and phosphorylation, and 
also aberrant expression of microRNAs. Interaction between genetic and 
environmental factors, modulated by epigenetic factors has been reported. 1α 
hydroxylase and 24 hydroxylase have been shown to be epigenetically 
controlled. Information regarding association between genetic and/or epigenetic 
factors and vitamin D status is inconclusive and warrants further study. 
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Population Based Approaches to Improve Vitamin D Status in India: 
Supplementation, Food Fortification and Educational Programs 
 There is protracted debate ongoing on issues pertaining optimal levels of 
intake of vitamin D, preferred form of vitamin D for human use and extraskeletal 
benefits of vitamin D. However, one thing is clear that Indians need more 
vitamin D. Vitamin D can be obtained from three sources: sun exposure 
(limitations of which has been discussed earlier), vitamin D supplements and 
vitamin D fortified foods. There is urgent need to prioritize development of 
national level programs to make available, quality-regulated and affordable 
vitamin D supplements and vitamin D fortified foods to the Indian populace. 
Very importantly, the government needs to implement measures to educate the 
Indian populace about the current status of vitamin D in India and also the 
modes to attain vitamin D sufficiency. 
 
Vitamin D Supplements Available in India 
 Supplements commonly available are - D3 (cholecalciferol), 1,25(OH)2D3 and 
1 alpha hydroxyl vitamin D3 (alfacalcidol). Some formulations have calcium 
too. Multivitamin formulations are also available and contain about 400 IU of 
D3.Vitamin D3 supplement of 60,000 IU is the highest selling one and is 
available in powder form in sachets or as oil-based capsules. Recommended 
dose on the label is once per week. The sachets indicate that half a sachet per 
week may also be taken.The other vitamin D supplements mentioned here are 
present in lower doses (0.25 µg or 500 IU) and daily intake (1–4 times/day) may 
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be recommended by the clinicians. Calcium supplementation is generally 
recommended with vitamin D intake. 
 The cost of a single dose of 60,000 IU of vitamin D3 is about INR 30. 
Intake of 60,000 IU of vitamin D3 per week may be advisable for a short 
duration, for patients with severe vitamin D deficiency, but a regular weekly 
dose may be lead to toxicity problems. A lower dose of vitamin D not exceeding 
the limit of 4000 IU per day would be advisable for otherwise healthy 
individuals to avoid toxicity. This will also reduce the cost of the supplement 
and become more affordable to the common people of India.  
 
Vitamin D Supplementation Studies in Ostensibly Healthy Indians 
 Vitamin D supplementation studies in ostensibly healthy were compiled. 
Supplementation resulted in significant improvement in vitamin D status, but a 
large proportion of the population had still did not attain sufficiency. The 
following study is noteworthy. In India, physicians often prescribe D3 60,000 IU 
per week for 8 weeks for vitamin D deficiency. Twenty two healthy Indians with 
subnormal serum 25(OH)D levels were supplemented with oral D3 60,000 
IU/week and calcium 1 gm/day for 8 weeks. At 8 weeks the mean 25(OH)D 
levels increased from 10.16 (3.96) ng/mL to 22.4 (6.8) ng/mL. Twenty two of 
the 23 subjects had 25(OH)D levels > 20 ng/mL. At the end of 12 months 
however, all the subjects were vitamin D deficient, once again. To sustain 
optimal 25(OH)D levels vitamin D supplementation would need to be ongoing 
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after the initial loading. Some supplementation studies, in ostensibly healthy 
adolescents and adult subjects, resulted in improved bone health. 
 More frequent and lower doses, not exceeding 4000 IU/day of vitamin D 
supplementation may be better for maintenance of serum 25(OH)D level. Most 
of the studies from India mention vitamin D status in terms of serum 25(OH)D 
levels as below or above 20 ng/mL (or 50 nmol/L). However, one must not lose 
sight of the fact that the aim of all interventions in terms of vitamin D status 
should be ≥ 30 ng/mL or above to derive both skeletal and extraskeletal benefits 
of this D-lightful nutrient, but with a precautionary stance to not exceed 100 
ng/mL. 
 
Need for Vitamin D Fortified Food Products in India 
 Vitamin D sufficiency via sun exposure is untenable for most Indians. 
Vitamin D rich dietary sources are mostly unaffordable and limited. Vitamin D 
supplements are unaffordable and not feasible as a population based approach. 
Fortification of widely consumed staple foods with vitamin D is the only viable 
solution towards attaining vitamin D deficiency in India. Unlike supplementation 
strategies, fortification of food with vitamin D poses a negligible risk of toxicity. 
 
Feasibility of Fortification of Foods with Vitamin D in India 
 Food fortification is a much more economically viable approach 
compared to vitamin D supplementation. While the cost of fortified food items 
will be more than unfortified foods, it will be lower than supplementation. 
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1. Adaptability to fortified food by the consumers is much better than to 
supplementation. Food fortification requires relatively less change in food 
habits and preferences, leading to better efficacy of fortification 
programs, lowered cost to the consumer and a larger profit to the food 
manufacturers. Clearly a win-win partnership for all. 
2. Food fortification may be a better choice compared to supplementation 
strategies, especially when targeting those who need it the most—women 
(including non-pregnant, pregnant and lactating), infants, children 
(especially girls, who are sidelined, more often than not, in India) and 
senior citizens.  
3. Use of staple foods such as chapatiflour, rice, etc., for fortification may 
have certain advantages over other fortification matrices. Indian 
government offers cereals, chapatiflour, rice, lentils, etc., at subsidized 
rates to the socioeconomically underprivileged citizens. Additionally, cost 
of these products is generally tightly regulated by the government. Thus, 
no large fluctuations are observed in the cost of these food items in the 
open market also. This will ensure continued consumption of these foods 
fortified with vitamin D, by those who avail of them and result in better 
and sustained economical feasibility of the fortification programs in the 
long run.  
4. Two vitamin D fortification studies in ostensibly healthy subjects were 
reported in the literature. Underprivileged toddlers, fed with fortified 
laddoos, resulted in significant increase in serum calcium and vitamin D 
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levels and also in total body less head (TBLH) bone mineral content 
(BMC).More cost effective food items could be fortified with vitamin D. 
 In another study, 776 subjects (boys and girls) were given fortified milk, 
which resulted in significant improvement in their vitamin D status.These results 
support the strategy of fortification of foods in India for redressing malnutrition 
problems in India. 
 
Food Items Which Could Be Fortified with Vitamin D in India 
1. Milk: The whole array of different grades of milk available could be 
fortified—whole milk, toned, double toned and skim milk. 
2. Milk curd and yogurt. 
3. Infant formulas. 
4. Butter, ghee(clarified butter) and oils, to use as spreads or to spike already 
cooked food. 
5. Soy milk, soy curd (tofu), orange juice and mango juice may be fortified 
to cater to the needs of the lactose intolerant individuals and those who 
are allergic to milk proteins. Processed cheese also has very low lactose 
content and is rich in calcium and may be fortified for the benefit of the 
lactose intolerant. Due to high prevalence of dyslipidemia, metabolic 
syndrome and cardiovascular diseases in India, these fortified items will 
also offer healthier choices to the general population. 
6. Widely consumed and affordable staple food items such as chapatiflour, 
maida(all purpose wheat flour, used to make bread and other bakery 
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products), rice and rice flour may be suitable vehicles for fortification 
strategies in the Indian scenario. 
 
Foods Fortified with Vitamin D Available in the Indian Market 
 Vitamin D fortified milk from Amul (an Indian dairy cooperative, located 
in Anand, Gujarat, India) is the only fortified milk product found in the general 
market. It is 4.5% fat, homogenized milk fortified with calcium 150 mg, vitamin 
A 75 µg and vitamin D 0.5 µg (20 IU), etc., per 100 mL. The expiry date of this 
milk is 120 days if the carton is unopened.  Some breakfast cereals fortified with 
vitamin D along with other micronutrients are also available. However, the 
exorbitant prices of these products are essentially prohibitive for consumption by 
the common people of India. 
 
 Impact of vitamin D deficiency on Indian Healthcare System 
 In India, bone diseases such as rickets, osteomalacia and osteoporosis 
have been (Nordin, 1966; Malhota and Mithal, 2008; Sp and Teotra, 2008) and 
still are widely prevalent. As per 2001 Census Report about 163 million people 
were above the age of 50 years. About 15%–20% of persons above the age of 50 
years would be developing osteoporosis . As presented in this review, BMD 
studies of ostensibly healthy Indians show that a significant proportion of 
younger Indians too are suffering from this silent disease. Some staggering 
figures and estimates pertaining rickets, osteomalacia and osteoporosis are 
mentioned in some reviews (Malhota and Mithal, 2008; Sp and Teotra, 2008). 
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 Vitamin D status in India is grim not only in the lower and but also in the 
upper socioeconomic classes. Considering the skeletal benefits of vitamin D, 
sufficiency in women of reproductive age would at the very least result in - 
improved women’s health, improved outcome of childbirth and birth of infants 
who may have a better chance of a healthy existence from the beginning of their 
lives. Vitamin D sufficiency in growing children would mean allowing for their 
full growth potential - physically, mentally and psychologically. In children, 
rickets translates into life-long deformity, osteomalacia - a painful and subpar 
existence. Sufficiency of vitamin D in elderly patients would insulate them from 
osteoporosis, a silent disease with constant threat of fractures, especially hip 
fractures resulting in the end of an independent existence. This fact indicates the 
heavy load on the healthcare system and the economy of the nation due to bone 
diseases alone. 
            This review of literature clearly depicted that extra skeletal effects of 
vitamin D and its beneficial role in, cardio vascular diseases, malignancies, 
respiratory tract infections and skin disorders emphasize the need of vitamin D 
supplementation in deficient individuals. Vitamin D improves insulin sensitivity 
and promotes insulin secretion in diabetes mellitus. 
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MATERIALS AND METHODS 
 This chapter includes the study design, participant recruitment, inclusion 
and exclusion criteria, sample size, Grouping the participants, anthropometric 
analysis, blood sample collection, biochemical parameters including 
determination of HbA1C, fasting and post prandial blood sugar, serum insulin, 
serum 25(OH)D, serum calcium,  renal function test including blood urea and 
serum creatinine, SGOT and SGPT, lipid profile including total cholesterol, 
triglycerides, HDL, LDL,. All the data collected are analyzed statistically by 
ANOVA method. 
 
Ethics Approval 
 The study was conducted after obtaining institutional ethical clearance 
certificate from Institutional Ethical Committee (IEC), Research Cell of Chennai 
Medical College Hospital and Research Centre (Affiliated to The Tamilnadu Dr. 
M.G.R. Medical University), Irungalur, Tiruchirapalli. The approval letter was 
enclosed as Appendix A. 
 
Study Design 
 A prospective, open labelled, randomized, single centre study performed 
in a tertiary care teaching hospital conducted at outpatient clinics. Total duration 
of the study period was 12 months (from June 2014 to May 2015). All patients 
were on oral first line anti-diabetic drug (Metformin) at the time of recruitment. 
All participants had a stable diet pattern.  
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Informed Consent 
            Written informed consent was obtained from each subject who were 
willing to participate in the study, after being explained personally about the 
purpose, potential risks regarding the study. 
    
Inclusion and Exclusion Criteria 
Inclusion Criteria 
 Our inclusion criteria were any Indian men and women aged between               
36-60 years who have been previously diagnosed as type 2 diabetes mellitus and 
under metformin treatment.  
 
Exclusion Criteria 
 Individual on other drugs (steroid, diuretics, statins, anti-epileptics, 
calcium and vitamin D supplements), type 1 diabetes, type 2 diabetes mellitus 
with ketosis or coma or reduced level of consciousness within the past 6 months, 
patient on insulin therapy (or) on anti diabetic drugs other than metformin, 
alcoholics, patients with hepatic dysfunction, renal dysfunction, renal calculi, 
hyperparathyroidism,  pregnancy and lactating mothers.  
 
Sample Size 
                   A total of 90 type II diabetes mellitus subjects in the age group of 36 
to 60 years on metformin therapy attending the diabetic clinic at Chennai 
Medical College Hospital and Research Centre, Irungalur, Tiruchirapalli were 
54 
 
included in this study. The selected subjects were grouped into three groups of 
30 each and the detailed study description was depicted in table 1. 
 
Table 1: Description of study groups (n=90) 
Group No. of 
subjects 
Subject descriptions 
I 30 
Type II diabetes mellitus on metformin therapy + 
normal serum vitamin 25(OH)D level 
II 30 
Type II diabetes mellitus on metformin therapy + 
decreased serum 25(OH)D level 
III 30 
Type II diabetes mellitus on metformin therapy + 
decreased serum 25(OH)D level + Cholecalciferol 
60000 IU weekly 
 
Group I: Includes 30 patients tested at zero time, 4 weeks, 8 weeks and 12 
weeks. The patients were considered as control groups where only metformin 
therapy followed and this group have normal vitamin D level. The age of 
patients for group 1 ranged from 36 – 60 years. 
Group II: Includes 30 patients tested at zero time, 4 weeks, 8 weeks and 12 
weeks. The patients were considered as test group 2 where metformin therapy 
followed and this group have  decreased vitamin D level. The age of patients for 
group 2 ranged from 36 – 60 years. 
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Group III: Includes 30 patients tested at zero time, 4 weeks, 8 weeks and 12 
weeks. The patients were considered as test group 3 where metformin therapy 
followed and this group have decreased vitamin D level and advised to take 
cholecalciferol 60000 IU weekly.  The age of patients for group 3 ranged from 
36 – 60 years. 
 All the subjects were provided with a general questionnaire which 
includes thorough past and present medical history and detailed medication 
information. None of the subjects included in this study are allowed to change 
their medication regimens during the entire study period in order to avoid the 
experimentation bias.  
 
Demographic and Clinical Data 
 Baseline demographic data including age, sex were determined, 
medications prescribed for diabetes treatment were documented using a 
structured questionnaire during the subject’s visit and validated from medical 
records. Clinical characteristics including body weight, height, body mass index, 
systolic and diastolic blood pressure of all subjects were measured.  
 
Anthropometric Measurements 
 All the measurements were recorded by a single observer  
 A digital scale was used for measuring the weight, which was adjusted to 
the nearest 0.1 kg. A wall – mounted stadiometer was used for measuring 
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the height and was adjusted to the nearest 0.1cm . BMI was calculated as 
BMI = Weight (kg) / height (m)2. 
  
Blood pressure determination 
 Blood pressure is measured is measured for the study subjects at 0,4,8 and 
12 weeks of study period. 
 
Table 2: Blood pressure levels 
Criteria Blood pressure levels 
Systolic 
(mmHg) 
Diastolic 
(mmHg) 
Normal Less than 120 Less than 80 
At risk (pre hypertension) 120-139 80-89 
High 140 and above 90 and above 
 
Blood sample collection 
 Before taking a blood sample, it is extremely important to be fully 
familiar with the collection system being used. It does not just make an 
unprofessional impression to fiddle about with the blood collection equipment, it 
will make the patient feel increasingly anxious, which will have a negative 
influence on the condition of the veins. The blood samples were collected from 
the patients before and after their diet to determine the fasting and post prandial 
glucose level determination respectively.  
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BIO CHEMICAL EVALUATION 
BLOOD SAMPLE COLLECTION 
                 About 4ml of overnight fasting  blood was collected during each visit 
by vene puncture under aseptic precautions in a sterile dry clean container and 
anticoagulant was added. The samples were centrifuged and used for the Fasting 
Glucose,Insulin,HbA1c,Lipid profile,Vitamin D3,SGOT, SGPT, Urea and 
Creatinine estimations.. Complete hemogram was done by Auto analyzer 
method.  
Blood samples were collected from the subjects to measure the 
biochemical parameters in all the three test groups on 0th day and at the end of 
4th, 8th and 12th weeks of the study period and the following biochemical 
parameters were determined, 
1. Plasma glycosylated haemoglobin (HbA1C) 
2. Fasting Blood Glucose  
3. Post Prandial Blood Glucose 
4. Serum Insulin 
5. Serum 25(OH)D 
6. HOMA – IR insulin resistance 
7. Lipid profile 
i. Total cholesterol 
ii. Triglycerides 
iii. High density lipoprotein (HDL) 
iv. Low density lipoprotein (LDL) 
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 About 2ml of anticoagulated blood collected at 2 hrs for Postprandial 
Glucose estimation 
 
Plasma glycosylated haemoglobin (HbA1C) 
 The levels of HbA1C were measured by high performance liquid 
chromatography (HPLC).  Glycosylated hemoglobin (HbA1c) is formed by the 
attachment of glucose to hemoglobin (the oxygen carrying protein found in red 
blood cells). The percentage of glycosylated hemoglobin in the blood reflects the 
average blood sugar levels over the preceding 2-3 months. If the blood sugar 
levels have been high in recent weeks, then HbA1c will also be greater                
(Table 3). 
 METHOD :- HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 
HPLC uses pressure for fast separations, controlled temperature, in-line 
detectors and gradient elution techniques. 
Table 3: Targets of HbA1c with its ranges 
 
 
 
 
 
HbA1c targets Percentages 
Non diabetics 4-5.9 
Diabetics >6.5 
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Fasting and Post prandial blood glucose  
METHOD:- GLUCOSE OXIDASE-PEROXIDASE METHOD  
PRINCIPLE:-  
Glucose in the sample is oxidised to gluconic acid and hydrogen peroxide by 
glucose oxidase. The enzyme peroxidase catalyses oxidative coupling of 4- 
aminophenozone with phenol to give pink coloured quinino -imine complex. 
The intensity of the colour is proportional to the concentration of glucose present 
in the sample 
Fasting blood glucose (FBS) Measures blood sugar levels either after an 8-12 
hrs of overnight fast  
Postprandial blood glucose (PP) Measures blood sugar 2 hours after intake of a 
meal or a specific amount of glucose (Oral Glucose Tolerance Test) 
 
Table 4: Interpretation of blood glucose levels 
 
 
 
 
 
 
 
 
Blood Glucose (mg/dL) Fasting blood Glucose 
Postprandial blood 
Glucose 
Normal glucose tolerance 70-110 70-140 
Impaired glucose 110-126 140-220 
Provisional diabetes 
mellitus >126 >200 
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Serum insulin  
• METHOD:- RADIOIMMUNOASSAY 
• PRINCIPLE:- 
The essential componenets of analytical system are Antigen (Insulin) to 
be determined , a fixed amount of labelled Antigen(Insulin) and a fixed 
limited amount of Antibody (antiInsulin antibody). This method offers 
considerable sensitivity and specificity. With antibodies of high binding 
affinity and radio labelled antigens of high specific activity, RIA 
measures substances at concentrations as low as 1 pmol/l. High 
specificity is due to highly specific nature of antigen-antibody interaction.  
The normal reference value after overnight fast is 2.6-24.9 µIU/mL. 
Insulin levels generally decline in patients with type 1 diabetes mellitus. 
In the early stage of type 2 diabetes, insulin levels are either normal or elevated. 
In the late stage of type 2 diabetes, insulin levels decline. During prolonged 
fasting, when the patient's glucose level is reduced to <40 mg/dL, elevated 
insulin level plus elevated levels of proinsulin and C-peptide suggest insulinoma. 
 
Serum 25(OH)D 
The 25-hydroxy vitamin D test is the most accurate way to measure 
vitamin D level It is measured by Chemiluminescence immunoassay. The 
normal range of vitamin D is measured as nanogram per milliliter (ng/mL). 
Vitamin D deficiency is defined as a 25(OH)D concentration < 20 ng/mL ; 
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vitamin D insufficiency as 21-29 ng/mL and sufficiency as 25(OH)D > 30 
ng/mL .  
PRNCIPLE:- 
The antiserum was raised against a bovine antiserum conjugate of vitamin 
D analog lacking the side chain. A radio iodinated vitamin D analog was used as 
tracer. Samples  and calibrators were deproteinised with acetonitrile and 
analyzed directly. 
4.HbA1c 
 METHOD :- HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 
HPLC uses pressure for fast separations, controlled temperature, in-line 
detectors and gradient elution techniques. 
HOMA-IR (Insulin resistance) 
 This method is used mainly for determining the resistance towards 
insulin. Insulin Resistance is determined by multiplying fasting blood sugar level 
in mmol/L with fasting serum insulin level in µIu/ml and further divided by 
22.5. The normal reference value is < 2.6.  
 
    HOMA-IR =   
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Lipid Profile: 
Total Cholesterol (TC) 
 This test may be measured any time of the day without fasting. However, 
if the test is drawn as part of a total lipid profile, it requires a 12-hour fast (no 
food or drink, except water). The normal range of the total cholesterol is 75-169 
mg/dL for those age 20 and younger and100-199 mg/dL for those over age 21. 
 
High Density Lipoprotein (HDL)  
 High levels linked to a reduced risk of heart and blood vessel disease. The 
reference value of HDL is greater than 40 mg/dL. This test may be measured any 
time of the day without fasting. However, if the test is drawn as part of a total 
lipid profile, it requires a 12-hour fast (no food or drink, except water)  
 
Low Density Lipoprotein (LDL)  
 High levels are linked to an increased risk of heart and blood vessel 
diseases, including coronary artery disease, myocardial infarction and 
death. Reducing LDL levels is a major treatment target for cholesterol-lowering 
medications.The ranges of LDL in blood are 
• Less than 70 mg/dL for those with heart or blood vessel disease and for 
other patients at very high risk of heart disease (those with metabolic 
syndrome)   
• Less than 100 mg/dL for high risk patients (multiple risk factors for 
coronary vascular diseases)  
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• Less than 130 mg/dL for individuals who are at low risk for coronary 
artery disease  
• Blood should be collected after a 12-hour fast (no food or drink, except 
water).  
Triglycerides (TG) 
 Elevated in patients with coronary artery diseases, diabetics, obese 
individuals, hepatic and thyroid disorders. Increased serum triglyceride level has 
a genetic predisposition also. The normal value is less than 150 mg/dl. Blood 
should be collected after a 12-hour fast (no food or drink, except water 
 
LIPID PROFILE ESTIMATION: 
The estimation of serum Triglycerides and total Cholesterol were done 
using Enzymatic method. The estimation of serum HDL cholesterol was done by 
Immuno-Inhibition method. 
LDL cholesterol was determined using the Friedwald’s formula 
LDL-C = Total Cholesterol ― ( HDL-C + VLDL-C) 
 VLDL - C = Triglycerides / 5 
The other biochemical parameters measured include: 
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• Serum Calcium estimation was done at the start of the study and at the 
end of 12th week. Serum Calcium was measured using Ion selective 
Electrode method 
• Blood Urea and serum creatinine were measured at the start of the study. 
Estimation of blood urea is by Urease GLDH method and Estimation of 
serum Creatinine was done by Modified JAFFE’S method. 
• Estimation of Liver enzymes ( SGOT,SGPT ) was done by IFCC method 
at the start of the study. 
Urine Analysis: 
             It was done at the start of the study. About 5 ml of urine was collected in 
a sterile container. Urine albumin,glucose and deposits were estimated . 
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STATISTICAL TESTS USED 
 
1. TESTS FOR NORMALITY 
 
• Shapiro –Wilk Test and Kolmogorov Smirnov Tests were used 
to test whether the data follow normal distributions or not.  
• Since the test was statistically not significant (p=0.679 i.e p>0.05), 
the data follow a normal distribution, and Parametric tests were 
used. 
 
2. DIFFERENCES BETWEEN INDEPENDENT GROUPS 
 
• Test of significance used was One-way ANOVA test. 
• The group means were compared with the overall mean of the 
sample 
• F Statistic was used to determine the significance. 
• Additionally post-hoc test (Bonferroni test) was used to compare 
the intergroup means. 
 
3. DIFFERENCES BETWEEN DEPENDENT GROUPS 
 
• Test of significance used was Two-way ANOVA (Repeated 
measures ANOVA) test. 
• The test was used to compare the same variable under 4 different 
instances [0,4,8 and 12 weeks] 
• Wilks’ Lambda was used to determine the significance 
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RESULTS 
 
 TABLE-1: Distribution of sample population according to age (N=90) 
Age Frequency Percent (%) Cumulative (%) 
30-39 14 15.5 15.5 
40-49 32 35.5 51.0 
50-59 37 41.1 92.1 
≥60 7 7.9 100 
Total 90 100.0  
 
 
 
 
 
 
 
 
Mean ± SD= 49.5± 7.44 
Median (IQR) =48.5(36-60) 
Comments:  
Majority of the sample population (41.1%) were in the age group of 50-59years 
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TABLE-2: Distribution of sample population according to gender (N=90) 
 
Gender Frequency Percent (%) 
MALE 54 60 
FEMALE 36 40 
TOTAL 90 100 
 
 
 
 
 
 
 
 
 
Comments:  
Majority of the sample population (60%) were males. 
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TABLE-3: Descriptive statistics of Weight, height and BMI (N=90) 
Measures Weight  
(kg) 
Height  
(cms) 
BMI 
Mean  79.2 166.8 28.5 
Median 79 168.1 28.7 
SD 9.04 8.02 2.88 
Range 57-96 148-180 20.06-34.02 
 
 
TABLE-4: Descriptive statistics of Mean Fasting Blood Sugar levels of 3 
groups at 0,4,8& 12 weeks (N=90) 
 
Measures 0 4 8 12 
Group I 119.9 117.4 148.5 112.5 
Group II 137.3 136.0 134.1 131.9 
Group III 139.2 134.9 130.7 124.9 
 
The mean difference in FBS in 3 groups was statistically significant (p=0.032) 
[p<0.05] according to one way ANOVA(F=11.69). 
Post hoc test revealed significant difference in mean FBS between groups              
II & III 
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TABLE-5: Descriptive statistics of Mean Postprandial Blood Sugar levels of 
3 groups at 0,4,8& 12 weeks (N=90) 
 
Measures 0 4 8 12 
Group I 159.9 157.5 154.6 147.7 
Group II 177.6 177 174.6 171.8 
Group III 177.9 175.0 170.7 163.6 
 
The mean difference in PPBS in 3 groups was statistically significant (p=0.024) 
[p<0.05] according to one way ANOVA (F=33.72). 
Post hoc test revealed significant difference in mean PPBS between groups II & 
III  
TABLE-6: Descriptive statistics of Mean Total Cholestrol levels of 3 groups 
at 0,4,8 & 12 weeks (N=90) 
Measures 0 4 8 12 
Group I 192.4 191.2 189.9 189 
Group II 194.9  194.1  193.3 192.6 
Group III 196.03 191.64 188.58 185.30 
 
The mean difference in Total Cholesterol in 3 groups was not statistically 
significant (p=0.14) according to one way ANOVA (F=10.08). 
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TABLE-7: Descriptive statistics of Mean TGL levels of 3 groups at 0,4,8 
&12 weeks (N=90) 
Measures 0 4 8 12 
Group I 234.7 233.3 231.8 230.5 
Group II 238.7 238.09 237.6 236.7 
Group III 238.6 235.1 227.25 226.01 
 
The mean difference in TGL  in 3 groups was statistically significant (p=0.045) 
[p<0.05] according to one way ANOVA (F=44.3). 
Post hoc test revealed significant difference in mean TGL between groups II & 
III 
TABLE-7: Descriptive statistics of Mean LDL levels of 3 groups at 0,4,8 
&12 weeks (N=90) 
Measures 0 4 8 12 
Group I 104.6 103.5 102.5 101.5 
Group II 109.9 111.9 109.4 108.5 
Group III 114.2 111.03 109.4 109.8 
 
The mean difference in LDL in 3 groups was not statistically significant 
(p=0.98) according to one way ANOVA (F=158.77). 
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TABLE-8: Descriptive statistics of Mean HDL levels of 3 groups at 0,4,8& 
12 weeks (N=90) 
Measures 0 4 8 12 
Group I 40 40.7 41.5 42 
Group II 38.5 39.1 39.7 40.3 
Group III 38.5 40.1 39.9 42.2 
 
The mean difference in HDL in 3 groups was not statistically significant 
(p=0.84) according to one way ANOVA (F=97.58). 
 
TABLE-9: Descriptive statistics of Mean Insulin Resistance levels of 3 
groups at 0,4,8& 12 weeks (N=90) 
Measures 0 4 8 12 
Group I 2.19 2.1 1.95 1.83 
Group II 3.49 3.4 3.22 3.1 
Group III 3.6 3.3 2.9 2.6 
 
The mean difference in Insulin Resistance  in 3 groups was statistically 
significant (p=0.037) [p<0.05] according to one way ANOVA (F=26.52). 
Post hoc test revealed significant difference in mean IR between groups II & III 
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TABLE-10: Descriptive statistics of Mean HbA1C levels of 3 groups at 
0,4,8& 12 weeks (N=90) 
Measures 0 4 8 12 
Group I 6.44 6.35 6.21 6.15 
Group II 7.36 7.27 7.17 6.81 
Group III 7.46 7.24 7.03 6.77 
 
The mean difference HbA1C groups was statistically significant (p=0.046)  
[p<0.05] according to one way ANOVA (F=102.4). 
Post hoc test revealed significant difference in mean HbA1C between groups II 
& III 
TABLE-11: Descriptive statistics of Mean Vitamin D levels of 3 groups at 
0,4,8& 12 weeks (N=90) 
Measures 0 4 8 12 
Group I 30.9 31.3 31.9 32.4 
Group II 14.33 14.88 16.05 17.13 
Group III 12.8 17 21.9 28.1 
 
The mean difference in Vitamin D level in 3 groups was statistically significant 
(p=0.037) [p<0.05] according to one way ANOVA (F=12.4). 
Post hoc test revealed significant difference in mean Vitamin D level between 
groups II & III 
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ANALYSIS OF VARIABLES FOR GROUP III [0,4,8,12 weeks] 
REPEATED MEASURES 
TABLE-12: Descriptive statistics of Mean FBS levels of Group III at 0,4,8& 
12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
FBS 0 
4 weeks 
8 weeks 
12 weeks 
139.2(136.8-141.6) 
134.9(132.5-137.3) 
130.7(128.2-133.1) 
124.9(121.8-127.9) 
6.49 
6.42 
6.52 
8.07 
1.18 
1.17 
1.19 
1.47 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.025      F= 351.0        df =3         p= 0.017 
Reduction in FBS over time after intervention was statistically significant 
[p<0.05]. 
 
TABLE-13: Descriptive statistics of Mean PPBS levels of Group III at 0,4,8 
& 12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
PPBS 0 
4 weeks 
8 weeks 
12 weeks 
177.9(174.8-181) 
175.0(172.5-177) 
170.7(168.2-173.1) 
163.6(159.6-167.9) 
8.2 
6.8 
6.6 
10.7 
1.5 
1.2 
1.2 
1.96 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.80      F= 103.99df=3         p=0.009 
Reduction in PPBS over time after intervention was statistically 
significant[p<0.05]. 
 
74 
 
TABLE-14: Descriptive statistics of Mean Total Cholestrol levels of Group 
III at 0,4,8 & 12 weeks (N=90) 
 
Variables Time Mean(CI) SD SE N 
TC 0 
4 weeks 
8 weeks 
12 weeks 
196.0(193.3-198.5) 
191.6(188.9-194.3) 
188.5(185.7-191.4) 
185.3(182.7-187.8) 
7.1 
7.1 
7.7 
6.7 
1.3 
1.3 
1.4 
1.2 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.051      F= 169.15df=3         p=0.041 
Reduction in TC over time after intervention was statistically significant 
[p<0.05]. 
 
TABLE-15: Descriptive statistics of Mean Triglycerides levels of Group III 
at 0,4,8& 12 weeks (N=90) 
 
Variables Time Mean(CI) SD SE N 
TGL 0 
4 weeks 
8 weeks 
12 weeks 
238.6(234.9-242.2) 
235.1(231.4-238.8) 
227.6(222.6-231.8) 
226.0(221.8-230.2) 
9.6 
9.9 
12.3 
11.2 
1.7 
1.8 
2.2 
2.0 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.336      F= 17.78df=3         p=0.033 
Reduction in TGL over time after intervention was statistically 
significant[p<0.05]. 
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TABLE-16: Descriptive statistics of Mean LDL levels of Group III at 0,4,8& 
12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
LDL 0 
4 weeks 
8 weeks 
12 weeks 
114.2(112-116) 
111.0(109-112) 
109.4(107-111) 
109.8(105-114) 
5.3 
4.7 
5.5 
11.4 
0.98 
0.86 
1.01 
2.09 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.386     F= 14.3df=3         p=0.09 
Reduction in LDL over time after intervention was not statistically 
significant[p<0.05]. 
 
TABLE-17: Descriptive statistics of Mean HDL levels of Group III at 
0,4,8& 12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
HDL 0 
4 weeks 
8 weeks 
12 weeks 
38.5(37.7-39) 
40.0(39.5-40.5) 
39.9(37.3-42.4) 
42.2(41.5-43) 
2.1 
1.4 
6.8 
2.0 
0.39 
6.26 
1.2 
0.36 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.208     F= 34.27df=3         p=0.07 
Rise in HDL over time after intervention was not statistically significant 
[p<0.05] 
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TABLE-18: Descriptive statistics of Mean IR levels of Group III at 
0,4,8&12 weeks (N=90)\ 
Variables Time Mean(CI) SD SE N 
IR 0 
4 weeks 
8 weeks 
12 weeks 
3.6(3.4-3.8) 
3.3(3.1-3.4) 
2.9(2.8-3.1) 
2.6(2.4-2.8) 
0.5 
0.5 
0.4 
0.4 
0.09 
0.09 
0.08 
0.09 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.021     F= 416.3df=3         p=0.025 
Reduction in IR over time after intervention was statistically significant[p<0.05]. 
 
 
TABLE-19: Descriptive statistics of Mean HbA1C levels of Group III at 0, 
4, 8 &12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
HbA1C 0 
4 weeks 
8 weeks 
12 weeks 
7.4(7.34-7.57) 
7.2(7.12-7.36) 
7.0(6.9-7.15) 
6.7(6.6-6.8) 
0.31 
0.32 
0.32 
0.32 
0.05 
0.05 
0.06 
0.05 
30 
30 
30 
30 
 
Wilk’s Lambda value = 0.002     F= 487.2df=3         p=0.029 
Reduction in HbA1C over time after intervention was statistically 
significant[p<0.05]. 
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TABLE-20: Descriptive statistics of Mean Vitamin D levels of Group III at 
0,4,8 & 12 weeks (N=90) 
Variables Time Mean(CI) SD SE N 
Vit.D 0 
4 weeks 
8 weeks 
12 weeks 
12.8(11.3-14.4) 
17.0(14.7-19.3) 
21.9(19.2-24.5) 
28.1(25.2-30.9) 
4.1 
6.0 
7.1 
7.6 
0.75 
1.1 
1.2 
1.3 
 
 
Wilk’s Lambda value = 0.066     F= 127.67df=3         p=0.016 
Rise in Vitamin D levels over time after intervention was statistically significant 
(p<0.016) 
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DISCUSSION 
                     Diabetes Mellitus is a metabolic disorder of multiple etiology with 
impairment of carbohydrate, protein and fat metabolism. This global pandemic 
principally involves T2DM, characterized by chronic hyperglycemia resulting 
from defective insulin secretion or insulin action or both. Type 2 Diabetes 
Mellitus accounts for 90 – 95 % and Type I accounts for 5 to 10% of diabetic 
population.. The number of subjects with type 2 diabetes mellitus is on the rise, 
due to the effects of age, sedentary nature of work and obesity. 
             Management of T2DM includes lifestyle modifications (diet 
control, regular exercises), oral anti-diabetic drugs , Parenteral agents including 
Insulin, GLP1 receptor agonists and Amylin agonists. Metformin (1,1-dimethyl 
biguanide), is a first line oral anti- diabetic drug. It primarily reduces hepatic 
glucose production and also improves peripheral glucose utilization. 
         Vitamin D deficiency is widespread in individuals irrespective of 
their age, gender, race and geography. Vitamin D is photosynthesized in the skin 
on exposure to UVB rays. Vitamin D deficiency is widely prevalent despite 
plentiful sunshine even in tropical countries like India. Vitamin D is a hormone 
related to skeletal integrity. Recently, the extra skeletal effects of vitamin D have 
evinced considerable interest. Vitamin D deficiency appears to be related to the 
development of diabetes mellitus type 2 and metabolic syndrome. Plasma 
25(OH)D or calcidiol (a summation of D3 and D2 forms) is the most reliable 
marker of vitamin D status. Immunoassays such as radioimmunoassay (RIA),  
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enzyme linked immunosorbant assay (ELISA), chemilumiescence immunoassay 
and protein binding assays are used in routine testing of 25(OH)D in clinical 
laboratories.  
The increased prevalence of diabetes mellitus is attributed to Low serum 
vitamin D status.31 Vitamin D supplementation to T2DM patients increases 
serurm 25(OH)D level.32 Studies in humans have shown that vitamin D 
supplementation in infancy reduces the risk of type 1 diabetes mellitus during 
early adulthood. As vitamin D modulates insulin receptor gene expression and 
insulin secretion, vitamin D deficiency is an environmental etiological factor for 
type 2 diabetes mellitus    
 Hence this study was conducted to study the prevalence of vitamin D 
deficiency and the effect of vitamin D on the glycemic conrol and lipid profile in 
T2DM patients. The study subjects represented type 2 diabetic patients under 
Metformin treatment. This study was undertaken in 90 T2DM patients on 
Metformin therapy (500mg OD), who attended the outpatient department of 
Chennai Medical College Hospital and Research Centre, Tiruchirapalli. The 
study population were divided into 3 groups of 30 each. A weekly oral dose of 
60000 I U of cholecalciferol was administered to the 30 T2DM subjects with 
vitamin D deficiency belonging to group 3. The biochemical parameters of all 
the three groups were evaluated at the end of 3rd month (12th week) and the 
results were statistical analysed by ANOVA method. Additionally, post-hoc test 
(Bonferroni test) was used to compare the intergroup means. 
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Vitamin D supplementation significantly reduces Fasting Blood Glucose, 
Post Prandial Blood Glucose and HbA1c levels (p< 0.05) in group III T2DM 
patients. Further an inverse relation between serum 25(OH) D and HbA1c level33 
was observed Vitamin D exerts this beneficial effect by direct and indirect 
mechanisms. Vitamin D promotes pancreatic β-cell function and increases 
insulin secretion in numerous ways.29 The presence of vitamin D receptors 
(VDR) and binding of 25(OH) D with vitamin D binding proteins (DBP) in β 
cells of pancreas33 leads to the transcription of genes regulated by 25(OH) D  
and facilitates the secretion of insulin from pancreatic β cells.Activation of 
vitamin D occurs in pancreatic β-cells by intracellular 1-α-Hydroxylase 
enzyme.34 Vitamin D by its direct action enhances insulin secretion by forming 
1,25(OH)2D3-RXR-VDR complex which binds to vitamin D responsive 
elements (VDRE) found in the insulin gene promoter region, enhancing the 
transcriptional activation of the insulin gene and increase insulin synthesis.35  
 Insulin secretion is a calcium-dependent process and is influenced by 
calcium influx through the cell membrane. Vitamin D indirectly promotes 
calcium influx into the β-cells of pancreas by regulating calbindin, a cytosolic 
calcium-binding protein found in β-cells  resulting in increased insulin 
synthesis.36 
  Vitamin D supplementation along with metformin in group III T2DM 
patients also significantly reduces Insulin Resistance as compared to group II 
T2DM patients with metformin monotherapy.  
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The mechanism by which vitamin D reduces insulin resistance is a 
complex one. Vitamin D enhances insulin sensitivity by stimulating the 
transcription of insulin receptor (INS-R) gene35 and thereby reduces insulin 
resistance.37 Further vitamin D exerts anti apoptotic effect by attenuating the 
expression of pro inflammatory cytokines such as IL-1, IL-6, TNF-α, NF-kβ 
involved in insulin resistance. Vitamin D also suppresses the renin gene reducing 
hyperglycemic induced increase in renin levels in pancreatic β cells and 
blockade of renin-angiotensin activity. This has been proposed as a novel target 
for management of diabetes and metabolic syndrome.38 Vitamin D 
supplementation also increases fasting serum insulin secretion.29,34,35 
 Regarding the analysis of lipid profile, Post- hoc test reveals a significant 
reduction in triglyceride (TGL) level in group III T2DM patients as compared to 
group II T2DM subjects. Vitamin D also reduces total cholesterol level and 
increases high density lipoprotein (HDL) level but insignificantly. Vitamin D 
exerts its action on lipid metabolism by activating transcriptional factor, 
peroxisome proliferator-activated receptor-δ (PPAR-δ). It is implicated in the 
regulation of fatty acid metabolism in skeletal muscles and adipose tissue.40 The 
inhibitory effect of vitamin D on lipids facilitates reduction in insulin resistance. 
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The highlight of the present study is the identification of a higher 
prevalence of vitamin D deficiency and insufficiency among T2DM study 
population. Vitamin D supplementation significantly increases serum 25(OH)D 
level in group III T2DM subjects.      
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SUMMARY AND CONCLUSION 
 
                       Diabetes has emerged as a major health problem worldwide, with 
serious health - related and socioeconomic impacts on individuals and 
populations. This pandemic growth of diabetes is due to transitioning 
demographic, socioeconomic, nutritional and lifestyle patterns. There is also an 
increased proliferation of diabetes mellitus in overweight and obese adults and 
children. Majority of this escalation is attributed to growth of type 2 diabetes 
mellitus (T2DM). 
                              The extra skeletal effects of vitamin D have evinced 
considerable interest.  Vitamin D deficiency has been proposed as a risk factor 
for type 2 diabetes. Vitamin D deficiency has been associated with increased 
insulin resistance in T2DM patients. Vitamin D decreases fasting blood glucose, 
post prandial blood glucose and HbA1c level in T2DM patients. Further Vitamin 
D decreases total cholesterol, triglycerides and increases HDL level in T2DM 
subjects. Vitamin D also increases insulin sensitivity by promoting insulin 
synthesis from pancreatic β cells. By these mechanisms, vitamin D can reduce 
the cardinal manifestations of metabolic syndrome including hyperglycemia, 
hypertriglyceridemia, obesity and poly cystic ovarian disease.  
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                       This study was conducted to study the prevalence of vitamin D 
deficiency and the effect of vitamin D on the glycemic control and lipid profile 
in T2DM patients. This study was undertaken in 90 T2DM patients on 
Metformin therapy (500mg OD), aged 36 to 60 years, who attended the 
outpatient departments of Chennai Medical College Hospital and Research 
Centre, Tiruchirapalli. The study population was divided into 3 groups of 30 
each. A weekly oral dose of 60000 I U of cholecalciferol was administered to the 
30 T2DM subjects with vitamin D deficiency belonging to group 3. Vitamin D 
status was evaluated using serum 25-hydroxy D level. 
The overview of this study highlighted the study design, participant 
recruitment, inclusion and exclusion criteria, sample size, grouping the 
participants, anthropometric analysis, blood sample collection, biochemical 
parameters including determination of fasting and post prandial blood glucose, 
fasting serum insulin, HbA1C, serum 25(OH)D, lipid profile including total 
cholesterol, triglycerides, LDL and HDL. All the data collected are analyzed  
statistically by ANOVA method. 
Combinations of metformin and cholecalciferol in group III T2DM 
patients with vitamin D deficiency significantly reduce fasting plasma glucose, 
postprandial plasma glucose and HbA1c levels. Further this combination also 
significantly reduce serum triglyceride level. There is also an insignificant rise in 
high density lipoprotein level as compared to metformin monotherapy in 
Type2DM with vitamin D deficiency. A significant increase in serum 25(OH) D 
level is also observed in group III T2DM patients.  
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CONCLUSION 
 
                       Vitamin D improves glycemic control in T2DM patients by 
lowering fasting blood glucose and HbA1c levels. An inverse relation between 
serum 25(OH)D  and HbA1c level in T2DM patients has been observed. 
Vitamin D also reduces triglyceride level and improves HDL level in T2DM 
patients. Further Vitamin D promotes insulin synthesis and improves insulin 
sensitivity in T2DM patients. Hence Vitamin D supplementation improves the 
glycemic control and can reduce or prevent the development of insulin resistance 
in T2DM patients.  Considering the multitude of diseases associated with 
vitamin D deficiency, increasing the population’s awareness of beneficial effect 
of vitamin D on health will be an important strategy overall.  
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3.0 1.0 48.0 m 58.0 163.00 21.83 0.0 7 132.0 172.0 9 18 188 233 109 38 3.06
4.0 7 128.0 168.0 9 22 185 227 107 39 2.78
8.0 7 124.0 164.0 8 26 183 221 104 42 2.51
12.0 6 118.0 158.0 7 32 180 216 102 43 2.13
2.0 59.0 m 65.0 175.00 21.22 0.0 7 134.0 174.0 10 17 190 231 110 40 3.21
4.0 7 130.0 170.0 9 20 187 225 108 40 2.92
8.0 7 128.0 168.0 9 22 181 220 107 40 2.78
12.0 7 120.0 161.0 8 30 179 215 104 41 2.25
3.0 60.0 m 82.0 169.00 28.71 0.0 7 136.0 176.0 10 15 192 231 108 37 3.36
4.0 7 132.0 172.0 9 18 188 225 106 38 3.06
8.0 7 128.0 168.0 9 22 185 221 103 39 2.78
12.0 7 122.0 162.0 8 29 181 217 101 39 2.38
4.0 52.0 M 75.0 165.00 27.55 0.0 7 132.0 172.0 9 19 187 234 108 39 3.06
4.0 7 128.0 168.0 9 30 185 228 107 39 2.78
8.0 7 126.0 166.0 9 32 181 225 105 40 2.64
12.0 6 118.0 157.0 7 40 179 220 101 40 2.13
5.0 55.0 M 76.0 172.00 25.69 0.0 7 130.0 171.0 9 20 188 232 110 40 2.92
4.0 7 126.0 167.0 9 30 186 229 107 40 2.64
8.0 7 122.0 162.0 8 36 182 224 104 41 2.38
12.0 6 116.0 155.0 7 40 180 218 103 42 2.00
6.0 39.0 F 58.0 163.00 21.83 0.0 8 146.0 185.0 12 12 190 231 110 40 4.15
4.0 8 142.0 182.0 11 19 187 226 109 40 3.82
8.0 7 138.0 178.0 10 31 181 221 107 40 3.51
12.0 7 132.0 172.0 9 38 180 216 104 41 3.06
Gr
o
u
p
S
e
r
i
a
l
n
o
A
g
e
S
e
x
W
e
i
g
h
t
k
g
H
e
i
g
h
t
m
B
M
I
_
N
E
W
W
e
e
k
s
H
b
A
1
C
F
B
S
P
P
B
S
F
a
s
t
i
n
g
S
e
r
u
m
I
n
s
u
l
i
n
µ
I
u
m
l
S
e
r
u
m
v
i
t
D
L
I
P
I
D
P
R
O
F
I
L
E
_
T
C
L
I
P
I
D
P
R
O
F
I
L
E
_
T
G
L
L
I
P
I
D
P
R
O
F
I
L
E
_
L
D
L
L
I
P
I
D
P
R
O
F
I
L
E
_
H
D
L
I
R
7.0 60.0 F 73.0 148.00 33.33 0.0 8 152.0 192.0 12 12 192 233 110 39 4.54
4.0 8 146.0 185.0 12 18 184 266 106 40 4.15
8.0 8 142.0 181.0 11 27 184 222 104 41 3.82
12.0 7 138.0 179.0 10 39 181 221 102 42 3.51
8.0 43.0 M 96.0 180.00 29.63 0.0 8 142.0 182.0 11 14 194 232 110 38 3.82
4.0 7 138.0 178.0 10 20 188 225 106 39 3.51
8.0 7 134.0 175.0 10 30 182 184 104 42 3.21
12.0 7 128.0 167.0 9 38 179 212 101 42 2.78
9.0 60.0 M 75.0 176.00 24.21 0.0 7 136.0 175.0 10 17 190 241 116 40 3.36
4.0 7 130.0 171.0 9 23 187 233 105 38 2.92
8.0 7 126.0 166.0 9 31 182 221 103 42 2.64
12.0 7 122.0 161.0 8 38 180 220 101 44 2.38
10.0 48.0 F 76.0 153.00 32.47 0.0 7 138.0 178.0 10 12 186 224 108 39 3.51
4.0 7 132.0 172.0 9 18 182 218 106 40 3.06
8.0 7 128.0 167.0 9 22 180 206 103 40 2.78
12.0 7 124.0 163.0 8 27 178 204 100 42 2.51
11.0 59.0 F 68.0 161.00 26.23 0.0 7 132.0 171.0 9 18 193 238 112 41 3.06
4.0 7 128.0 168.0 9 22 189 232 109 43 2.78
8.0 7 126.0 165.0 9 24 186 228 108 41 2.64
12.0 6 118.0 157.0 7 33 183 224 105 45 2.13
12.0 41.0 M 82.0 177.00 26.17 0.0 7 136.0 175.0 10 15 196 240 116 38 3.36
4.0 7 132.0 172.0 9 18 193 235 112 40 3.06
8.0 7 130.0 169.0 9 20 189 231 109 4 2.92
12.0 7 122.0 161.0 8 29 186 226 109 43 2.38
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13.0 38.0 M 69.0 168.00 24.45 0.0 8 140.0 151.0 11 11 197 242 114 37 3.66
4.0 7 136.0 176.0 10 14 192 235 110 40 3.36
8.0 7 132.0 172.0 9 18 198 230 106 40 3.06
12.0 7 126.0 166.0 9 25 185 227 105 45 2.64
14.0 47.0 F 70.0 156.00 28.76 0.0 8 142.0 181.0 11 10 198 244 118 39 3.82
4.0 7 138.0 178.0 10 12 194 238 112 40 3.51
8.0 7 134.0 174.0 10 16 191 234 108 42 3.21
12.0 7 129.0 168.0 9 23 189 229 104 43 2.80
15.0 49.0 F 68.0 160.00 26.56 0.0 8 148.0 189.0 12 7 197 241 112 39 4.31
4.0 8 144.0 184.0 11 8 190 235 108 41 3.98
8.0 8 140.0 181.0 11 11 183 228 104 41 3.66
12.0 7 135.0 174.0 10 17 188 226 102 42 3.23
16.0 52.0 M 79.0 170.00 27.34 0.0 8 146.0 186.0 12 8 194 246 116 40 4.15
4.0 8 142.0 182.0 11 10 191 238 112 42 3.82
8.0 7 138.0 178.0 10 12 188 234 109 44 3.51
12.0 7 134.0 173.0 10 18 183 232 107 45 3.21
17.0 52.0 F 58.0 170.00 27.00 0.0 8 142.0 181.0 11 10 200 247 118 41 3.82
4.0 7 138.0 178.0 10 12 194 240 115 43 3.51
8.0 7 132.0 171.0 9 19 181 235 113 41 3.06
12.0 7 129.0 168.0 11 23 186 238 113 46 3.44
18.0 39.0 F 65.0 156.00 26.71 0.0 8 144.0 183.0 12 9 202 248 120 43 4.34
4.0 8 140.0 180.0 11 11 195 241 114 44 3.66
8.0 7 136.0 176.0 10 14 188 236 115 45 3.36
12.0 7 131.0 170.0 9 20 188 240 114 47 2.94
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19.0 54.0 F 68.0 163.00 25.59 0.0 8 155.0 195.0 13 5 204 249 122 39 4.86
4.0 8 150.0 195.0 13 5 197 246 119 41 4.70
8.0 8 146.0 187.0 12 8 194 243 117 43 4.15
12.0 8 140.0 180.0 11 11 189 240 116 43 3.66
20.0 52.0 F 86.0 166.00 31.21 0.0 8 148.0 187.0 12 7 203 251 121 39 4.31
4.0 8 144.0 184.0 11 9 198 247 118 40 3.98
8.0 8 140.0 180.0 11 11 193 242 117 41 3.66
12.0 7 135.0 174.0 10 17 187 239 141 42 3.23
21.0 53.0 M 88.0 172.00 29.75 0.0 7 134.0 173.0 10 16 206 254 124 37 3.21
4.0 7 130.0 171.0 9 20 201 251 121 39 2.92
8.0 7 126.0 167.0 9 24 196 246 118 40 2.64
12.0 7 121.0 160.0 8 31 190 241 116 42 2.27
22.0 58.0 M 85.0 173.00 28.40 0.0 7 134.0 173.5 10 17 195 238 113 38 3.21
4.0 7 132.0 171.0 9 18 193 233 112 40 3.06
8.0 7 124.0 165.0 8 26 199 230 111 42 2.51
12.0 7 120.0 119.0 8 31 184 252 150 40 2.25
23.0 55.0 M 69.0 169.00 24.16 0.0 7 132.0 172.0 9 18 192 240 116 38 3.06
4.0 7 126.0 166.0 9 24 187 234 115 39 2.64
8.0 7 120.0 161.0 8 30 187 232 113 41 2.25
12.0 6 118.0 157.0 7 33 184 231 112 41 2.13
24.0 55.0 F 66.0 158.00 26.44 0.0 8 142.0 181.0 11 10 209 248 119 29 3.82
4.0 7 138.0 177.0 10 12 203 243 116 41 3.51
8.0 7 134.0 173.0 10 16 203 240 115 42 3.21
12.0 7 128.0 167.5 9 24 199 234 113 41 2.78
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25.0 48.0 F 76.0 160.00 29.69 0.0 8 144.0 185.0 11 8 212 250 121 38 3.98
4.0 8 140.0 180.0 11 10 209 243 118 39 3.66
8.0 7 136.0 176.0 10 15 206 232 115 41 3.36
12.0 7 131.0 171.0 10 20 202 236 118 42 3.23
26.0 43.0 M 86.0 170.00 29.76 0.0 7 134.0 174.0 10 15 191 235 101 39 3.21
4.0 7 128.0 167.0 9 22 187 228 107 40 2.78
8.0 7 124.0 163.0 8 26 183 230 105 42 2.51
12.0 7 120.0 160.0 8 31 182 212 103 43 2.25
27.0 48.0 M 75.0 178.00 23.67 0.0 7 133.0 173.0 10 15 192 235 118 38 3.18
4.0 7 131.0 170.0 9 20 184 227 109 39 2.94
8.0 7 126.0 165.0 9 24 187 218 107 40 2.64
12.0 7 121.0 159.0 8 29 181 214 104 41 2.36
28.0 58.0 F 72.0 158.00 28.84 0.0 7 138.0 177.0 10 13 207 206 117 39 3.51
4.0 7 132.0 172.0 9 18 206 240 115 40 3.06
8.0 7 126.0 167.0 9 24 203 237 113 42 2.64
12.0 7 124.0 163.0 8 27 200 234 120 43 2.51
29.0 59.0 F 78.0 156.00 32.05 0.0 8 140.0 179.0 11 10 206 247 120 37 3.66
4.0 7 136.0 176.0 10 14 202 240 117 38 3.36
8.0 7 130.0 171.0 9 20 199 237 115 39 2.92
12.0 7 127.0 165.0 9 25 198 232 114 41 2.67
30.0 46.0 M 86.0 159.00 34.02 0.0 7 136.0 176.0 10 14 190 238 110 39 3.36
4.0 7 132.0 172.0 9 18 184 225 106 41 3.06
8.0 7 126.0 165.0 9 24 183 210 123 42 2.64
12.0 7 100.0 161.0 8 29 179 214 113 38 1.95
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2.0 31.0 43.0 F 89.0 162.00 33.91 0.0 8 148.0 188.0 12 6 197 242 113 38 4.31
4.0 8 146.0 186.0 12 6 196 241 111 39 4.15
8.0 8 144.0 184.0 11 8 195 240 111 40 3.98
12.0 8 142.0 182.0 11 9 194 238 110 40 3.82
32.0 37.0 M 86.0 171.00 29.41 0.0 8 146.0 196.0 12 7 195 240 111 39 4.15
4.0 8 144.0 194.0 11 8 194 239 110 40 3.98
8.0 8 142.0 192.0 11 9 194 238 109 41 3.82
12.0 8 140.0 190.0 11 10 193 237 108 42 3.66
33.0 59.0 F 83.0 158.00 33.25 0.0 7 131.0 171.0 9 20 188 235 109 39 3.04
4.0 7 129.0 169.0 9 22 187 234 109 39 2.80
8.0 7 126.0 166.0 9 23 186 233 107 41 2.64
12.0 7 124.0 154.0 8 25 185 231 107 42 2.51
34.0 60.0 M 93.0 175.00 30.37 0.0 7 130.0 170.0 9 20 185 229 105 42 2.92
4.0 7 128.0 168.0 9 22 185 229 105 42 2.78
8.0 7 125.0 165.0 9 24 184 228 104 42 2.62
12.0 7 123.0 163.0 8 25 183 228 104 43 2.49
35.0 54.0 F 86.0 159.00 34.02 0.0 7 132.0 172.0 9 19 187 233 108 39 3.06
4.0 7 130.0 170.0 9 20 187 232 187 41 2.92
8.0 7 128.0 168.0 9 22 186 232 107 41 2.78
12.0 7 125.0 165.0 9 23 184 230 103 42 2.62
36.0 52.0 M 89.0 176.00 28.73 0.0 7 135.0 176.0 10 16 192 237 109 39 3.23
4.0 7 133.0 173.0 10 17 190 237 108 39 3.15
8.0 7 132.0 171.0 9 18 189 235 107 40 3.06
12.0 0 129.0 169.0 9 19 193 239 110 39 2.90
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37.0 43.0 M 91.0 178.00 28.72 0.0 8 143.0 183.0 11 9 192 238 109 40 3.85
4.0 8 141.0 181.0 11 10 191 236 109 41 3.76
8.0 8 139.0 179.0 11 10 190 235 108 41 3.64
12.0 7 137.0 177.0 10 10 188 233 107 42 3.48
38.0 48.0 M 79.0 178.00 24.93 0.0 8 141.0 181.0 11 12 196 239 111 38 3.69
4.0 7 138.0 177.0 10 12 195 239 110 39 3.51
8.0 7 135.0 175.0 10 13 194 238 110 39 3.33
12.0 7 133.0 173.0 10 15 193 237 109 39 3.18
39.0 46.0 M 86.0 169.00 30.11 0.0 7 135.0 175.0 10 16 192 236 107 41 3.23
4.0 7 133.0 173.0 10 16 192 236 107 41 3.15
8.0 7 131.0 172.0 9 18 191 235 107 41 3.04
12.0 7 129.0 169.0 9 18 191 235 106 42 2.90
40.0 51.0 M 79.0 179.00 24.66 0.0 7 131.0 171.0 9 19 193 234 108 40 2.94
4.0 7 129.0 169.0 9 20 193 233 107 41 2.87
8.0 7 127.0 167.0 9 21 192 233 107 41 2.76
12.0 7 125.0 165.0 9 23 192 233 106 41 2.62
41.0 43.0 F 69.0 162.00 26.29 0.0 7 144.0 184.0 11 8 195 234 110 39 3.98
4.0 8 142.0 182.0 11 9 194 234 110 39 3.82
8.0 8 143.5 184.0 11 10 194 234 109 39 3.76
12.0 7 142.0 183.0 10 11 193 233 109 40 3.61
42.0 60.0 M 85.0 174.00 28.08 0.0 7 135.0 175.0 10 16 194 234 111 39 3.23
4.0 7 133.0 173.0 9 17 193 234 110 40 3.09
8.0 7 131.0 171.0 9 18 193 233 110 41 3.01
12.0 7 129.0 169.0 9 19 192 232 108 41 2.90
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43.0 52.0 F 79.0 156.00 32.46 0.0 8 150.0 191.0 12 6 204 249 122 37 4.48
4.0 7 148.0 188.0 12 6 201 248 120 38 4.31
8.0 7 146.0 186.0 12 7 198 247 117 39 4.15
12.0 6 143.0 183.0 11 8 196 246 115 39 3.95
44.0 57.0 F 77.0 154.00 32.47 0.0 8 151.0 191.0 12 5 204 252 123 37 4.51
4.0 8 148.0 188.0 12 6 203 251 122 37 4.31
8.0 8 146.0 186.0 12 7 202 249 122 38 4.15
12.0 8 145.0 185.0 11 8 201 248 121 39 4.08
45.0 39.0 M 93.0 174.00 30.72 0.0 8 140.0 180.0 11 11 196 240 110 38 3.66
4.0 7 137.0 177.0 10 12 196 240 110 39 3.48
8.0 7 135.0 175.0 10 13 195 238 108 39 3.33
12.0 7 132.0 173.0 10 15 194 238 109 41 3.16
46.0 46.0 M 84.0 173.00 28.07 0.0 7 130.0 171.0 10 20 195 239 109 41 3.11
4.0 7 128.0 168.0 9 21 195 239 110 41 2.78
8.0 7 125.0 166.0 9 23 194 239 110 41 2.62
12.0 7 123.0 163.0 8 25 193 239 107 41 2.49
47.0 59.0 M 79.0 168.00 27.99 0.0 7 133.0 173.0 9 19 192 237 107 39 3.09
4.0 7 130.0 170.0 9 20 194 238 108 40 2.92
8.0 7 129.0 168.0 9 21 195 239 110 41 2.80
12.0 7 127.0 169.0 9 22 195 243 104 41 2.73
48.0 57.0 F 71.0 156.00 29.17 0.0 8 145.0 185.0 11 9 194 238 107 37 4.01
4.0 8 143.0 183.0 11 8 194 237 107 38 3.88
8.0 8 141.0 181.0 11 9 193 237 106 38 3.79
12.0 8 139.0 179.0 11 10 193 236 106 39 3.64
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49.0 46.0 M 85.0 178.00 26.83 0.0 7 135.0 175.0 10 16 195 239 110 37 3.23
4.0 7 133.0 173.0 9 17 194 238 109 38 3.09
8.0 7 131.0 171.0 9 19 194 239 108 39 2.94
12.0 7 129.0 169.0 9 20 193 239 108 39 2.87
50.0 52.0 M 89.0 180.00 27.47 0.0 7 133.0 173.0 9 19 193 234 107 40 3.09
4.0 7 130.0 170.0 9 19 192 234 107 40 3.02
8.0 7 128.0 168.0 9 21 192 238 106 41 2.78
12.0 7 126.0 165.0 10 23 191 233 106 41 3.11
51.0 55.0 M 86.0 175.00 28.08 0.0 7 137.0 177.0 10 11 197 240 111 39 3.35
4.0 7 135.0 175.0 10 14 195 235 109 39 3.23
8.0 7 133.0 173.0 9 15 195 238 110 39 3.09
12.0 7 131.0 171.0 9 17 194 238 128 40 2.97
52.0 55.0 M 78.0 160.00 30.47 0.0 7 120.0 163.0 8 28 196 236 105 41 2.31
4.0 7 118.0 160.0 8 30 195 235 104 42 2.21
8.0 6 117.0 158.0 7 31 193 234 104 42 2.11
12.0 6 116.0 156.0 7 33 192 233 103 42 2.00
53.0 48.0 F 57.0 159.00 22.55 0.0 8 145.0 185.0 11 8 198 241 108 38 4.01
4.0 8 143.0 183.0 11 9 198 239 107 38 3.92
8.0 8 141.0 181.0 11 9 197 238 107 39 3.79
12.0 8 139.0 179.0 11 10 196 236 106 40 3.64
54.0 36.0 M 78.0 177.00 24.90 0.0 7 137.0 179.0 10 13 198 240 111 38 3.48
4.0 7 135.0 177.0 10 13 197 240 110 39 3.37
8.0 7 133.0 175.0 11 14 196 239 109 40 3.51
12.0 7 129.0 172.0 10 15 195 240 109 40 3.09
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55.0 48.0 M 85.0 168.00 30.12 0.0 7 127.0 169.0 9 22 194 240 109 38 2.76
4.0 7 125.0 177.0 8 23 194 239 109 39 2.50
8.0 7 123.0 165.0 9 23 193 238 108 40 2.58
12.0 7 128.0 163.0 8 25 193 237 107 40 2.56
56.0 40.0 M 96.0 174.00 31.71 0.0 8 147.0 187.0 12 7 200 244 111 36 4.17
4.0 8 145.0 185.0 11 8 198 243 110 37 4.08
8.0 8 143.0 183.0 11 8 197 242 112 38 5.30
12.0 8 141.0 181.0 11 9 196 241 109 39 3.79
57.0 38.0 M 88.0 175.00 28.73 0.0 8 141.0 181.0 10 10 196 241 111 38 3.62
4.0 7 143.0 189.0 11 11 196 241 110 39 3.71
8.0 7 139.0 179.0 10 11 195 240 110 39 3.54
12.0 7 134.0 175.0 10 13 194 239 109 40 3.31
58.0 56.0 M 77.0 170.00 26.64 0.0 7 133.0 173.0 9 19 195 240 110 39 3.09
4.0 7 131.0 171.0 9 19 194 240 110 39 2.94
8.0 7 128.0 169.0 9 20 193 239 129 40 2.75
12.0 7 126.0 163.0 8 21 193 239 108 41 2.55
59.0 48.0 F 83.0 159.00 32.83 0.0 8 127.0 156.0 12 21 200 245 111 35 3.67
4.0 8 147.0 184.0 11 22 198 247 111 36 4.07
8.0 8 147.0 187.0 11 23 197 243 111 37 3.92
12.0 8 139.0 179.0 10 23 197 238 107 38 3.54
60.0 58.0 F 96.0 172.00 32.45 0.0 7 139.0 179.0 10 24 196 237 107 37 3.54
4.0 7 137.0 177.0 10 13 196 237 106 38 3.38
8.0 7 135.0 175.0 10 14 195 237 106 38 3.30
12.0 7 133.0 172.0 10 15 195 238 107 39 3.18
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1.0 61.0 46.0 M 89.0 178.00 28.09 0.0 7 123.0 163.0 8 28 194 237 107 38 2.40
4.0 7 120.0 160.0 8 30 194 236 106 39 2.25
8.0 6 1,118.0 158.0 7 32 193 235 105 40 20.15
12.0 6 115.0 155.0 7 36 195 237 107 40 1.99
62.0 37.0 M 88.0 172.00 29.75 0.0 7 121.0 161.0 8 30 195 236 106 38 2.27
4.0 6 118.0 158.0 7 32 194 235 105 39 2.13
8.0 6 116.0 156.0 7 34 193 234 104 40 2.00
12.0 6 114.0 154.0 7 36 194 235 105 40 1.89
63.0 39.0 F 68.0 155.00 28.30 0.0 6 119.0 159.0 7 32 194 234 105 40 2.14
4.0 6 114.0 156.0 7 34 193 233 104 40 1.97
8.0 6 114.0 154.0 7 36 191 230 103 41 1.89
12.0 6 111.0 151.0 6 38 195 237 105 41 1.75
64.0 37.0 M 85.0 180.00 26.23 0.0 6 117.0 157.0 7 34 193 236 104 42 2.02
4.0 6 114.0 154.0 7 36 192 234 103 42 1.89
8.0 6 112.0 152.0 6 41 189 229 101 43 1.77
12.0 7 109.0 149.0 6 26 195 239 109 38 1.64
65.0 42.0 M 94.0 176.00 30.35 0.0 7 125.0 165.0 8 28 194 238 108 39 2.53
4.0 7 122.0 162.0 8 30 193 237 107 40 2.38
8.0 7 119.0 159.0 8 32 193 236 106 41 2.23
12.0 6 117.0 157.0 7 30 191 234 104 41 2.11
66.0 37.0 M 82.0 172.00 27.72 0.0 6 115.0 155.0 7 36 192 234 104 41 1.90
4.0 6 113.0 153.0 6 38 190 232 103 42 1.79
8.0 6 110.0 150.0 6 40 189 231 102 42 1.66
12.0 6 107.0 147.0 6 42 187 230 101 43 1.53
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67.0 46.0 F 74.0 163.00 27.85 0.0 6 113.0 153.0 6 38 190 231 103 41 1.79
4.0 6 111.0 155.0 6 40 188 230 102 42 1.67
8.0 6 108.0 148.0 6 42 186 230 101 43 1.55
12.0 6 105.0 145.0 6 45 185 226 100 44 1.50
68.0 39.0 M 77.0 176.00 24.86 0.0 7 121.0 161.0 6 30 195 238 108 39 1.64
4.0 7 119.0 159.0 8 31 194 237 106 40 2.20
8.0 6 117.0 157.0 7 33 193 236 105 41 2.11
12.0 6 114.0 154.0 7 36 192 235 104 42 1.89
69.0 47.0 M 92.0 177.00 29.37 0.0 7 123.0 163.0 8 28 196 240 109 38 2.40
4.0 7 121.0 161.0 8 29 196 239 108 39 2.33
8.0 6 118.0 158.0 7 32 193 236 106 41 2.13
12.0 6 115.0 155.0 9 34 192 234 104 41 2.41
70.0 42.0 F 76.0 158.00 30.44 0.0 7 127.0 167.0 8 24 198 242 111 37 2.57
4.0 6 124.0 164.0 8 26 197 241 110 38 2.42
8.0 7 122.0 162.0 8 28 196 240 109 39 2.29
12.0 7 120.0 160.0 7 31 194 239 107 39 2.07
71.0 59.0 M 83.0 164.00 30.86 0.0 6 117.0 157.0 7 34 191 234 104 42 1.99
4.0 6 115.0 155.0 7 35 190 233 103 42 1.90
8.0 6 113.0 153.0 6 37 189 232 102 43 1.70
12.0 6 109.0 149.0 6 40 187 230 101 44 1.56
72.0 46.0 M 90.0 174.00 29.73 0.0 6 119.0 159.0 7 31 193 236 106 39 2.17
4.0 6 117.0 157.0 7 33 192 234 106 40 2.02
8.0 6 115.0 155.0 7 35 191 232 105 41 1.93
12.0 6 112.0 15.0 6 38 196 238 106 42 1.77
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73.0 57.0 F 82.0 162.00 31.25 0.0 7 123.0 163.0 8 28 195 236 105 40 2.40
4.0 7 121.0 161.0 8 30 194 235 104 41 2.27
8.0 7 118.0 158.0 7 32 194 234 103 42 2.13
12.0 6 116.0 155.0 7 33 193 232 102 42 2.03
74.0 60.0 F 72.0 158.00 28.84 0.0 6 121.0 161.0 8 30 193 233 104 41 2.27
4.0 6 118.0 158.0 7 32 192 232 103 42 1.98
8.0 6 115.0 155.0 7 34 191 231 102 43 1.90
12.0 6 113.0 153.0 7 35 192 232 103 44 1.81
75.0 42.0 M 81.0 168.00 28.70 0.0 6 118.0 155.0 7 36 190 230 102 40 1.95
4.0 6 113.0 153.0 6 38 189 229 101 41 1.79
8.0 6 110.0 150.0 6 40 187 227 100 41 1.71
12.0 6 108.0 148.0 6 41 185 225 98 42 1.63
76.0 39.0 M 82.0 170.00 28.37 0.0 6 110.0 150.0 6 40 188 229 101 44 1.66
4.0 6 107.0 147.0 6 42 187 228 99 45 1.53
8.0 6 105.0 145.0 6 45 186 226 98 45 1.40
12.0 6 103.0 142.0 5 46 185 223 96 46 1.29
77.0 58.0 F 78.0 160.00 30.47 0.0 7 127.0 167.0 9 24 197 240 110 37 2.67
4.0 7 125.0 165.0 8 26 196 238 108 38 2.53
8.0 6 122.0 162.0 8 29 195 236 107 39 2.29
12.0 6 120.0 159.0 7 31 193 233 105 40 2.19
78.0 59.0 F 80.0 157.00 32.46 0.0 7 126.0 166.0 9 24 197 241 111 37 2.64
4.0 7 124.0 164.0 8 26 196 239 109 38 2.51
8.0 7 121.0 161.0 8 28 195 237 107 39 2.36
12.0 7 120.0 160.0 8 29 194 234 104 40 2.25
Gr
o
u
p
S
e
r
i
a
l
n
o
A
g
e
S
e
x
W
e
i
g
h
t
k
g
H
e
i
g
h
t
m
B
M
I
_
N
E
W
W
e
e
k
s
H
b
A
1
C
F
B
S
P
P
B
S
F
a
s
t
i
n
g
S
e
r
u
m
I
n
s
u
l
i
n
µ
I
u
m
l
S
e
r
u
m
v
i
t
D
L
I
P
I
D
P
R
O
F
I
L
E
_
T
C
L
I
P
I
D
P
R
O
F
I
L
E
_
T
G
L
L
I
P
I
D
P
R
O
F
I
L
E
_
L
D
L
L
I
P
I
D
P
R
O
F
I
L
E
_
H
D
L
I
R
79.0 52.0 M 82.0 169.00 28.71 0.0 6 118.0 168.0 7 32 193 233 103 41 2.13
4.0 6 116.0 156.0 7 34 192 232 102 42 2.00
8.0 6 113.0 153.0 7 36 191 231 103 43 1.87
12.0 6 110.0 151.0 7 38 190 229 101 43 1.77
80.0 46.0 M 79.0 164.00 29.37 0.0 7 127.0 167.0 9 24 196 237 108 38 2.67
4.0 7 124.0 164.0 8 26 194 236 106 40 2.51
8.0 7 122.0 162.0 8 28 192 235 105 41 2.38
12.0 7 119.0 159.0 7 30 190 233 103 42 2.12
81.0 56.0 M 82.0 162.00 31.25 0.0 7 120.0 160.0 8 30 191 234 103 41 2.28
4.0 7 118.0 158.0 7 32 190 233 102 42 2.13
8.0 6 116.0 156.0 7 34 189 231 101 42 2.00
12.0 6 113.0 153.0 7 36 190 228 101 43 1.87
82.0 38.0 F 66.0 154.00 27.83 0.0 6 119.0 159.0 7 32 189 232 100 41 2.14
4.0 6 117.0 157.0 7 34 188 231 99 42 2.02
8.0 6 116.0 154.0 7 36 187 230 99 43 1.92
12.0 6 112.0 152.0 6 38 185 227 98 43 1.77
83.0 60.0 M 89.0 171.00 30.44 0.0 6 123.0 163.0 8 28 193 235 105 44 2.40
4.0 7 120.0 160.0 8 30 190 234 104 45 2.25
8.0 6 118.0 158.0 7 32 189 234 103 45 2.13
12.0 6 115.0 155.0 7 34 187 230 99 46 1.99
84.0 52.0 F 77.0 163.00 28.98 0.0 6 114.0 154.0 7 36 186 228 98 38 1.89
4.0 6 112.0 158.0 6 38 185 227 98 38 1.77
8.0 6 110.0 147.0 6 40 184 226 97 39 1.66
12.0 6 107.0 143.0 6 42 181 220 96 40 1.53
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85.0 48.0 M 86.0 166.00 31.21 0.0 6 116.0 154.0 7 34 188 230 100 42 2.00
4.0 6 114.0 152.0 8 36 186 229 98 43 2.17
8.0 6 112.0 149.0 6 38 184 228 97 44 1.77
12.0 6 109.0 145.0 6 40 180 226 96 45 1.64
86.0 47.0 F 71.0 159.00 28.08 0.0 7 125.0 162.0 8 26 196 237 107 39 2.53
4.0 7 122.0 160.0 8 28 195 235 106 40 2.38
8.0 7 120.0 158.0 8 30 193 234 105 41 2.25
12.0 6 118.0 153.0 7 33 186 229 98 42 2.13
87.0 46.0 M 78.0 166.00 28.31 0.0 6 113.0 150.0 6 38 185 227 97 40 1.79
4.0 6 110.0 146.0 6 40 183 226 96 40 1.66
8.0 6 108.0 143.0 6 42 181 224 95 41 1.55
12.0 6 106.0 140.0 6 44 179 220 93 42 1.44
88.0 57.0 F 69.0 159.00 27.29 0.0 6 117.0 157.0 7 34 188 231 101 41 2.02
4.0 6 115.0 155.0 7 36 187 230 100 42 2.20
8.0 6 113.0 153.0 6 38 186 228 99 42 1.79
12.0 6 110.0 150.0 6 41 184 224 97 42 1.66
89.0 54.0 M 76.0 161.00 29.32 0.0 6 114.0 154.0 7 36 186 229 100 42 1.89
4.0 6 112.0 152.0 6 38 184 227 99 43 1.77
8.0 6 110.0 150.0 6 40 183 225 98 44 1.66
12.0 6 107.0 147.0 6 42 180 221 96 44 1.53
90.0 59.0 F 77.0 155.00 32.05 0.0 7 128.0 168.0 9 22 198 243 111 41 2.78
4.0 7 126.0 166.0 9 24 197 239 109 41 2.64
8.0 7 124.0 164.0 8 26 196 238 108 42 2.51
12.0 7 121.0 161.0 8 28 194 236 106 42 2.36
CASE SHEET 
Registration no:        Date:  
 
Name:      Age:    Sex: 
 
Address: 
 
Occupation:     Marital Status:   Weight (Kg):    
   
 
Height (Cm):        BMI:       
 
Complaints: 
 
 
H/o Present illness: 
 
 
Past History 
 
 
Personal History: 
 
 
Family History: 
 
 
Obstetric History: 
  
General Examination: 
 
 
Systemic examination:  
 
 
Investigation: 
1. Plasma glycosylated hemoglobin (HbA1C) 
2.  Fasting Blood Sugar 
3. Post Prandial blood Sugar 
4. Serum insulin 
5. Serum 25(OH)D 
6. Serum Calcium 
7. Blood Urea 
8. Serum Creatinine 
9. Lipid profile - Total cholesterol, Triglycerides, High density lipoprotein, Low density 
lipoprotein 
10. Liver function tests - SGOT,SGPT 
11. Urine albumin 
Sugar  
Deposits  
 
 
Treatment:  
 
 
 
 
  Signature of the Investigator 
CONSENT FORM 
(To be obtained from subject) 
Introduction: 
             You are requested to participate in a study conducted in department of 
Pharmacology, Chennai Medical College Hospital & Research Centre, Irungalur, 
Tiruchirapalli, Tamil Nadu entitled. 
“A study on the prevalence of Vitamin D deficiency and the effect of   
Vitamin D on the Glycemic control and lipid profile in type II Diabetes Mellitus 
patients in a Rural Tertiary Care Hospital.” 
 Your participation in this study is Voluntary. You at liberty to participate/ 
withdraw from the study. Please read this consent form carefully and ask the Consultant, 
any questions you may have about the study before signing. 
Explanation of Procedure: 
 If you agree to participate in this study, we will ask some question to you and 
collect relevant information/ Blood sample. You may be examined by the investigator, 
data from the study will be used for research purposes only. The results of the study will 
not to be given to you directly. There will be no cost to you participating in this study. 
Potential benefits: 
 Your participation will help us to know the risk factor of this problem and results 
of this study will be beneficial for future generations. 
Assurance of Confidentiality: 
 The information concerning your participation in the study will be kept 
confidential to the full extent permitted by law and used only for scientific purposes. No 
one except members of the research team will have access the results. Your name will not 
be disclosed in any report or released in any way. 
Patient Consent: 
 I have read the explanation about this study and have been given an opportunity to 
discuss it and to ask questions. I have not received any money for participating in this 
study. 
 
 
Signature of Subject   Signature of Witness    Date 
 
 
     Signature of Researcher 
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